Adiv Baruch is a leader in the High-tech industry in the last 34 years. Mr. Baruch is acting as the Chairman of the Israeli export and International Cooperation Institute leading Israel export which in 2019 exceeded 114 Billion US ($) of export as over 50% are High-tech related industries.
Mr. Baruch is also acting as the Chairman of the Innovation and Technology Institute in Israel, the Chairman of Elad health care solutions, Elad systems and few more public traded companies in Israel (TSE) and other exchanges (NASDAQ, OTC, HK).
Today Mr. Baruch is leading the Young Entrepreneurs Organization and has been actively involved in leading the global innovation of Israel. Mr. Baruch was a founding member of Ness Technologies, a leading IT software company. Mr. Baruch is globally involved in the Medical IT solutions, Cyber companies, Smart Cities initiatives and Financial technologies and solutions. Mr. Baruch also served as a board member of Bank of Jerusalem. Throughout the years, Mr. Baruch has led tenth of merger and acquisitions and capital raise of over one Billion US ($). Mr. Baruch has his own philanthropic organization and has been a YPO member for over 17yrs.
Mr. Baruch served in the Israeli Navy and holds an Engineering degree from the Technion,
the leading engineering institute in Israel.
David Leffler, CEO Israeli Ministry of Economy and Industry
May 2020 - Present, CEO, Ministry of Economy and Industry
2015-2020, Chairman of Israel Southern District Panning Committee
2013-2015, Director General, Ministry of Environmental Protection
2007-2013, General Manager, ETHOS – the Haifa Municipality Art, Culture and Sports Association Company.
2007-2013, General Manager, Haifa International Film Festival
2005-2006, Director General, Ministry of Science and Technology
2001-2003, Director General, Ministry of Science, Culture and Sports
1998-2001, Israel Representative, Metallia Holding (European-based hotel development group)
1995-1998, Marketing, Commercial Real Estate
1992-1994, Director General, Israel Employment Service
1991-1992, Business Development, C.I.D. Investment Company
1989-1991, Advisor to Chairman, Knesset Finance Committee
1987-1989, Researcher, Beit-Berl Research Center
1985-1986, Assistant to Prime Minister's Policy Advisor, Prime Minister's Office
1981-1984, Parliamentary Assistant to Yitzchak Rabin, Knesset
2007-2010, Israeli Military Industry, Chairman of the Board's Marketing Committee
2002-2003, One Voice Israel, Founder and Director General
1995-1998, Israel Electric Corporation, Chairman of the Board's Tender Committee, Finance Committee Member
1988-1992, Ashot Ashkelon Industries Ltd., Member of the Board
Advisory Committee, Open Landscape Institute
Member, Judging Committee, President's Award for Volunteerism
Hebrew University, Jerusalem, MBA - major in Marketing and Banking, 1994
Hebrew University, Jerusalem, MA in Political Science (with Honors), 1987
Hebrew University, Jerusalem, BA in Political Science, 1984
Frans van Houten
Frans van Houten is CEO of Royal Philips, a position he has held since April 2011. As CEO, he is also Chairman of the Board of Management and the Executive Committee.a
He is passionate about innovation, entrepreneurship and business transformation to drive competitiveness and customer value.
He is extending Philips’ leadership in health technology as the company focuses on its purpose to improve people’s health and well-being through meaningful innovation, with the goal of improving 2.5 billion lives per year by 2030.
Frans drives Philips’ strategic agenda to provide healthcare technology solutions in support of seamless, patient-centered care across the health continuum, starting with healthy living and prevention, precision diagnosis and personalized treatment, through to care in the home – where the cycle to healthy living begins again. He leads the company’s initiatives to help empower consumers to take more care of their own health and to provide healthcare solutions – suites of systems, smart devices, software and services – to customers and health systems.
He first joined Philips in 1986 and has held multiple global leadership positions across the company on three continents, including the role of co-CEO of the Consumer Electronics division. Frans’ team has driven the transformation and revitalization of the Philips portfolio to become a focused health technology company through targeted divestment, acquisition and organic business development. This is exemplified by the sale of the television business in 2012; the audio and video businesses in 2014 and the IPO of Philips Lighting on the Amsterdam Euronext stock exchange in May 2016. At the same time, Philips has invested in a number of acquisitions that strengthen the company’s portfolio, among them medical device leaders Volcano and Spectranetics, respiratory care leader RespirTech, remote cardiac diagnostics and monitoring leader BioTelemetry, and population health management leaders Wellcentive and VitalHealth, as well as others in digital pathology, neurology, pregnancy & parenting, healthcare informatics and ultrasound.
We’re guided by our purpose of improving people's health and well-being through meaningul innovation, with the goal of improving 2.5 billion lives per year by 2030.
As a seasoned business leader, Frans served as Co-Chair at the World Economic Forum in Davos in 2017. He was one of the initiators and currently co-chair of the WEF Platform to Accelerate the Circular Economy. A proponent of a united, single European market, Frans is also a member of the European Round Table of Industrialists, an advocacy organization comprising the 50 largest European multinationals. He is co-founder and advocate of NL2025, a platform of Dutch influencers who support initiatives to create a better future for the Netherlands in the areas of education, sustainable growth and a vital society.
He was appointed a member of the Board of Directors of Novartis in February, 2017.
Frans holds a Master's degree in Economics and Business Management from Erasmus University in Rotterdam and, since 2014, has served as chairman of the Supervisory Board of the Erasmus University Trust Fund. Frans was named one the world’s top 20 business leaders in 2017 by influential global business magazine, Fortune. Its citation stated: “We lean toward CEOs with vision — those impacting the world beyond their companies. The 20 star executives are doing nothing less than defining the future of business.
Frans is married and has four children. He lives near Amsterdam and enjoys contributing to community projects, sailing, skiing, running, gardening and art.
Prof. Ran D Balicer, MD, Ph.D, MPH
Ran D Balicer, MD, Ph.D, MPH
Founding Director, Clalit Research Institute
Chief Innovation Officer, Director of Innovation Division
Clalit Health Services, Israel
Public Health Department, Faculty of Health Sciences
Ben-Gurion University of the Negev, Israel
Prof. Ran Balicer, MD, PhD, MPH serves as Chief Innovation Officer for Clalit - Israel's largest healthcare organization. He also serves as Founding Director of the Clalit Research Institute, the WHO Collaborating Center on Non-Communicable Diseases Research, Prevention and Control. In these roles, he is responsible for strategic planning, development and implementation of novel organization-wide interventions and of innovative technology and data-driven tools, for improving healthcare quality, reducing disparities and increasing care effectiveness.
Since 2020, Prof. Balicer was appointed Chair of Israel's National Experts Panel on COVID-19 and serves as a senior advisor to the Israeli Government and Prime Minister Office on the COVID-19 pandemic response.
Prof Balicer is Full Professor and Track Director of the MPH program at the Ben-Gurion University School of Public Health, Israel, and has been serving as Chair of the Israeli Society for Quality in Healthcare since 2013.
Prof. Balicer serves as Commissioner for the Lancet and Financial Times Healthy Futures 2030 International Commission that aim at harnessing innovation globally to improve the health and wellbeing of young individuals. He also serves in senior advisory groups to the World Health Organization (WHO) Regional Office for Europe, and is involved in projects focusing on chronic diseases monitoring, prevention and control, use of big data and artificial intelligence in healthcare provision and care integration.
Harold F. Wolf
Harold (Hal) Wolf III is the President and CEO of the Healthcare Information and Management Systems Society (HIMSS), a mission-driven non-profit global advisor and thought leader supporting the reform of the global health ecosystem through the power of information and technology.
With a membership of 80,000 around the world, HIMSS serves the global health communities with focused operations across North America, Europe, United Kingdom, the Middle East and Asia Pacific.
Wolf is respected internationally as a healthcare and informatics leader, with areas of expertise in mhealth, product development, integrated care models, marketing, distribution, information technology and large-scale innovation implementation.
Before joining HIMSS, Wolf served at The Chartis Group as Director; Practice Leader of Information and Digital Health Strategy. Prior to The Chartis Group, he served as the Senior Vice President and Chief Operating Officer of Kaiser Permanente’s, The Permanente Federation, representing more than 16,000 physicians. Wolf also held executive positions at MTV Networks, Time Warner, and served as a Senior Advisor to McKinsey & Co.
Dr. John D. Halamka
John D. Halamka, M.D., M.S., president of the Mayo Clinic Platform, leads a portfolio of platform businesses focused on transforming health care by leveraging artificial intelligence, connected health care devices and a network of trusted partners.
Trained in emergency medicine and medical informatics, Dr. Halamka has been developing and implementing health care information strategy and policy for more than 25 years.
Prior to his appointment at Mayo Clinic, he was chief information officer at Beth Israel Deaconess Medical Center, where he served governments, academia and industry worldwide. He is a practicing emergency medicine physician.
As the International Healthcare Innovation Professor at Harvard Medical School, Dr. Halamka helped the George W. Bush administration, the Obama administration and governments around the world plan their health care information strategies.
Dr. Halamka completed his undergraduate studies at Stanford University, earned his medical degree at the University of California, San Francisco, and pursued graduate work in bioengineering at the University of California, Berkeley. He completed his residency at Harbor — UCLA Medical Center in the Department of Emergency Medicine.
Dr. Halamka has written a dozen books about technology-related issues, hundreds of articles and thousands of posts on the Geekdoctor blog. He was elected to the National Academy of Medicine in 2020. He and his wife also run Unity Farm Sanctuary in Sherborn, Massachusetts – the largest animal sanctuary in New England, which includes 300 animals, 30 acres of agricultural production and a cidery.
Prof. Arnon Afek
Prof. Arnon Afek is the Associate Director General, the Acting Director of Sheba General Hospital and the Chairman of the Department of Medical Administration at Sheba Medical Center. He assumed these positions after completing his tenure as the Director General (DG) and the Associate Medical DG of the Israeli Ministry of Health (2014-17). In the MOH, Prof Afek led the reforms in Mental Care, the regulation of Cannabis for medical use and public transparency in the publishing the outcomes of hospitals "Quality Indicators".
For his outstanding accomplishments and contributions to the Israeli Healthcare system, he received in 2019, the "Ot Yakir Hamedina", the highest award given each year to two senior civil servants.
In 2020 he was chosen as a member of the National Corona Professional Advisory Board, taking an active role in consulting the national corona supervisor on national health policy.
He is the Founding Chairman of the National Council on Pathology and Forensic Medicine.
In 2015, Prof. Afek was personally appointed as a member of the Bureau of Governors of the OECD Health Committee, taking a role in designing health policy in the OECD.
Since 2011, Prof. Afek serves as the Director of the NY State/American MD Program and Professor of Public Health at the Sackler School of Medicine and the Coller School of Management at Tel Aviv University.
He is a Visiting Professor at the Nicosia University Medical School, Cyprus.
In 2018, Prof Afek was nominated the Chairman of the Israeli Medical Association World Federation (IMA WF) and in 2019, he was elected the Chairman of the Association of Hospitals' Directors.
Previously, Prof. Afek was the Director of Medical Affairs, Acting Head of the Emergency Services of the Israeli Ministry of Health (2012-2014) and the Deputy Director of Sheba General Hospital (2007-2012).
Prof. Afek is a Colonel (Res) and a member of the IDF-MC Helsinki (IRB) Committee. He has previously served as the Head of Occupational Medicine and Medical Classification Branches as well as the Chairman of the Department of Medical Administration at the IDF Medical Corps (2004-7).
Dr. Arnon Afek received his medical training at the Hebrew University and Hadassah School of Medicine (1981-1987), residency in Anatomical Pathology at the Sheba Medical Center and fellowship in Medical Administration (Board Certified Cum Laude) at the Sheba Medical Center and at the Ministry of Health.
He completed M.A in Health Administration Cum Laude at Ben-Gurion University (2000-2002).
He is a graduate of the Wexner Senior Leadership Executive Program (WSLP 16), Kennedy School of Government at Harvard University.
Prof. Afek has published more than 150 peer reviewed papers in medical journals such as NEJM, JAMA, Lancet and Circulation and has received numerous awards, including the Tel Aviv University Rector's Award for Excellence in Teaching, the Kellerman Award and the Goldberg Award, both for research in Cardiology; the Israel National Quality Award (twice) and the Award of Excellence in Military Medicine.
He chaired the Committee that recommended the establishment of the new Sheldon & Miriam Adelson Medical School in Ariel University.
In 2016, he received the Israeli Civil Service Commission Award for reducing bureaucracy in physician licensing and Quality Improvement Award for advancing quality of care in Neonatal Units throughout Israel.
In 2017, Prof Afek was awarded the Society for Patients' Rights in Israel Certificate of Recognition for his contribution to patient's healthcare in reforming Mental Healthcare in Israel.
He lecturers at numerous medical conferences and delivered The John M. Eisenberg, M.D. International Lecture at The Commonwealth Fund's 18th Annual International Symposium on Health Care Policy.
He is married to a Pediatric Dentist, Dr. Limor Afek. They live in Rosh Ha’ayin with their two children Shahar and Oren.
Michael J. Dowling
Michael Dowling is one of health care’s most influential voices, taking a stand on societal issues such as gun violence and immigration that many health system CEOs shy away from. As president and CEO of Northwell Health, he leads a clinical, academic and research enterprise with a workforce of more than 72,000 and annual revenue of $13.5 billion. Northwell is the largest health care provider and private employer in New York State, caring for more than two million people annually through a vast network of nearly 800 outpatient facilities, including 220 primary care practices, 52 urgent care centers, home care, rehabilitation and end-of-life programs, and 23 hospitals. Northwell also pursues pioneering research at the Feinstein Institutes for Medical Research and a visionary approach to medical education highlighted by the Zucker School of Medicine, the Hofstra Northwell School of Graduate Nursing and Physician Assistant Studies, and one of the nation’s largest medical residency and fellowship programs.
Mr. Dowling’s leadership has been invaluable to Northwell’s consistent expansion and prominence. In 2020, he successfully navigated the health system through the first COVID-19 epicenter in the US, detailing his experiences in Leading Through a Pandemic: The Inside Story of Humanity, Innovation, and Lessons Learned During the COVID-19 Crisis.
Prior to becoming president and CEO in 2002, Mr. Dowling was the health system’s executive vice president and chief operating officer. Before joining Northwell Health in 1995, he was a senior vice president at Empire Blue Cross/Blue Shield. Mr. Dowling served in New York State government for 12 years, including seven years as state director of Health, Education and Human Services and deputy secretary to the governor. He was also commissioner of the New York State Department of Social Services. Before his public service career, Mr. Dowling was a professor of social policy and assistant dean at the Fordham University Graduate School of Social Services, and director of the Fordham campus in Westchester County.
Mr. Dowling has been honored with many awards over the years, including his selection as the Grand Marshal of the 2017 St. Patrick’s Day Parade in New York City; induction into the Irish America Hall of Fame; the 2012 B’nai B’rith National Healthcare Award, the Ellis Island Medal of Honor, the 2011 Gail L. Warden Leadership Excellence Award from the National Center for Healthcare Leadership, the 2011 CEO Information Technology Award from Modern Healthcare magazine and the Healthcare Information and Management Systems Society, the National Human Relations Award from the American Jewish Committee, the Distinguished Public Service Award from the State University of New York’s Nelson A. Rockefeller College of Public Affairs and Policy, an Outstanding Public Service Award from the Mental Health Association of New York State, an Outstanding Public Service Award from the Mental Health Association of Nassau County, the Alfred E. Smith Award from the American Society for Public Administration, and the Gold Medal from the American Irish Historical Society. For 12 consecutive years, Modern Healthcare has ranked Mr. Dowling on its annual list of the “100 Most Influential People in Healthcare.” He was also ranked No. 44 among large company CEOs in the US and was the nation’s top-ranking health care/hospital CEO on Glassdoor’s “Top CEOs in 2019” list.
Mr. Dowling is past chair of the Healthcare Institute and the current chair of the Institute for Healthcare Improvement (IHI). He is a member of the Institute of Medicine of the National Academies of Sciences and the North American Board of the Smurfit School of Business at University College, Dublin, Ireland. He also serves as a board member of the Long Island Association. He is past chair and a current board member of the National Center for Healthcare Leadership (NCHL), the Greater New York Hospital Association (GNYHA), the Healthcare Association of New York State (HANYS) and the League of Voluntary Hospitals of New York. Mr. Dowling was an instructor at the Center for Continuing Professional Education at the Harvard School of Public Health.
Mr. Dowling grew up in Limerick, Ireland. He earned his undergraduate degree from University College Cork (UCC), Ireland, and his master’s degree from Fordham University. He also has honorary doctorates from Queen’s University Belfast, University College Dublin, Hofstra University, Dowling College and Fordham University.
Dr. Michael (Miki) Halberthal
Dr. Michael (Miki) Halberthal is the General Director of Rambam Health Care Campus. Born in Tel Aviv in 1958, he is married and the father of four. Dr. Halberthal earned his M.D. in 1986, from the Technion-Israel Institute of Technology. His postgraduate training was completed at Rambam Health Care campus in Pediatrics and Pediatric Critical Care. As one of Rambam's leading postgraduate trainees, Dr. Halberthal was chosen to pursue a further subspecialty fellowship in Pediatric Cardiac Clinical Care at the world-renowned Brompton & Harefield Institute in London, U.K. After returning to Israel, Dr. Halberthal successfully established the Pediatric Cardiac Critical Care Service at Rambam, which continues to be one of the most active and successful services of its kind. In 1996, Dr. Halberthal completed a combined advanced clinical and research fellowship at the University of Toronto and the Hospital for Sick Children in Canada. In addition to numerous hospital activities, Dr. Halberthal completed his M.H.A. in Health and Hospital Administration at Tel Aviv University's Recanati School of Business Administration (2012).
Since 2001, Dr. Halberthal has held various professional leadership positions at Rambam, including serving as the Director of Pediatric Cardiac Critical Care, Director of Hospital-wide Emergency Triage, and Senior Staff Physician in the Pediatric Intensive Care Unit of Rambam. In 2009, he joined the Executive Leadership at Rambam and as the Director of Medical Operations. At the end of 2013 Dr. Halberthal was appointed Deputy Director of Rambam, primarily responsible for medical human resources; allied medical services; safety, quality, and risk management; emergency preparedness and the international trauma school and became the hospital’s General Director in 2019.
Dr. Halberthal served for over 30 years in the Israel Defense Forces Airborne Rescue and Evacuation Unit. He was actively involved in the coordination of international civilian air rescue and transport of emergency care patients.
A Clinical Lecturer (Educator) in the Technion’s The Ruth & Bruce Rappaport Faculty of Medicine, Dr. Halberthal is active in research and has published scholarly articles in the areas of hospital management, pediatric critical care, trauma and mass casualty preparedness, and airborne medicine. He is an active and highly regarded lecturer and teacher to medical students, residents and fellows, nursing staff and students, and allied health professionals in those domains of expertise.
Prof. Sam Shah
Professor Sam Shah is Chief Medical Strategy Officer for Numan. Sam’s interests span digital health, clinical leadership and public health. Sam is a digital health technology advisor to a number of healthcare and technology companies, spanning a range of industries including telecommunications, assessment of apps, scaling new technology into the NHS and workforce solutions. Sam was previously Director of Digital Development for NHS England and NHSX, where he was responsible for digital development of the ecosystem and leading on a number of national transformation programmes. Sam has worked on a number of initiatives including the flagship project to digitise urgent care in the NHS. Sam headed up the national learning and development programme for NHS England, which considered different channels to access healthcare using technology.
President of Sociedade Beneficente Israelita Brasileira Albert Einstein. Graduated in Medicine at the Faculty of Medicine of the University of São Paulo. He has a medical residency in General Surgery and Surgery of the Digestive System at the Hospital das Clínicas of the Faculty of Medicine of the University of São Paulo. Master in Surgery of the Digestive System by the same institution. Fellow of the American College of Surgeons qualified in the Art and Science of Surgery.
The Honorable Victor Fedeli
The Hon. Victor Fedeli is a lifelong entrepreneur, successful business person, author, and philanthropist, serving as Ontario’s Minister of Economic Development, Job Creation and Trade, and Chair of Cabinet.
Vic’s business experience led his firm Fedeli Corporation to be ranked 34th in the Top 50 Best Places to Work in Canada in 1989. It also served him well, when he was elected to two terms as Mayor of the City of North Bay from 2003 to 2010. As Mayor, Vic focused on fiscal prudence and economic development, restoring hope and solvency to North Bay.
In 2011 Vic was elected to the Ontario Legislature, and is now serving his third term as Member of Provincial Parliament (MPP) for Nipissing. In 2018, his party unanimously elected him to serve as Interim Leader of the Official Opposition. Vic served ten terms on the Board of the North Bay and District Chamber of Commerce, served as Director with Global Vision, and has served on many agencies, boards, and commissions, often as Chair. He is married to local humour writer Patty, and is always seen in one of his trademark yellow ties.
As Chief of Innovation, Dominick charts the course for MVP's major strategic initiatives to ensure MVP is positioned to serve its communities in the long-term. He previously served as MVP’s Executive Vice President of Informatics and Business Development.
Dominick has three decades of experience in leveraging health information technology and best-in-class business strategies to drive growth in transformation, start-up and turnaround situations. He served as the President and Chief Operating Officer for Hudson Headwaters Health Network, Managing Director, Business Development for HealthShare at InterSystems Corporation, and CEO at Hixny, a leading health information exchange in NY. He currently serves on the Hixny Board of Directors and the Hudson Valley Community College Foundation Board of Trustees.
Dr. Craig Hersh
Dr. Craig Hersh is the Senior Clinical Officer and Regional Vice President for Anthem Northeast, as well as Chief Medical Officer for Empire BlueCross BlueShield in New York. He is a Board-Certifiedphysician in Family Medicine and held additional qualifications in Sports Medicine, at one time serving as a Team Physician for the NY Giants. Prior to joining Anthem he worked as a Vice President for Accolade, a company specializing in patient engagement and navigation. Previously he worked as a Chief Medical Officer at Holy Name Medical Center and as a Medical Director for both Aetna and WellCare. He is a graduate of Tulane University and the SUNY Upstate Medical School in Syracuse, NY.
In 2016 Mr. Schneider has taken up the role of Group CIO at the healthcare group Asklepios Kliniken GmbH, which is one of the leading private operators of hospitals and healthcare facilities in Germany.
Before he has been the Chief Information Officer (CIO) at the University medical Center Hamburg-Eppendorf for 8 Years.
From 2003 to 2008, he succeeded as a program manager at Siemens AG Healthcare Sector running complex customer projects to improve healthcare processes by integrating clinical workflows with IT and medical devices. Before this – from 1998 to 2003 – Mr. Schneider worked at Siemens Business Services as a senior consultant for e-banking solutions.
During his work at Siemens, he was the winner of the Siemens Top Plus award in Dubai as one of the leading Project Manager worldwide in 2003. In 2005 he invented and established the Imaging Science Institute (www.isi-erlangen.de) which was a joint research center between Siemens and the University Hospital of Erlangen to improve and develop medical devices, IT-Systems and processes directly in a clinical environment.
In 2011, the HIMSS Association as the first digital hospital in Europe honored the UKE with the EMRAM Stage 7 Award. In 2015 the CIO Magazin and Computerwoche honored Mr. Schneider with the „CIO of the year award” (category innovation).
Mr. Assaf Barnea is a seasoned entrepreneur and venture professional, with extensive, multidisciplinary experience in building innovation platforms and leading commercialization processes in healthcare. He leads Sanara Ventures, a healthcare innovation fund backed by Phillips and Teva.
In addition to leading Sanara, Mr. Barnea chairs the Life Science Advisory Board at The Israel Export Institute, on behalf of the Israeli government, promoting and advancing the export of Israeli technologies in the medical, biotech, pharma and digital fields in global markets. A valued consultant, Mr. Barnea also advises the World Bank’s IFC venture capital team and is a co-founder of the IFC’s Tech Emerge initiative; a unique acceleration platform that connects healthcare startups from around the world with leading corporations and hospitals in emerging economies. On December 2018, Tech Emerge Health has won the world bank group president’s award for innovation.
Formerly, Mr. Barnea was one of the founders of CardioSense, a medtech startup company that developed a probe for early shock detection in various medical settings.
Before lending his multidisciplinary acumen to Sanara Ventures, Assaf served as CEO of Kinrot Ventures, spearheading its acquisition by Hutchison Water in 2012. Prior to this, he headed business development at Mekorot, Israel’s national water company, where he oversaw the establishment of WaTech, the Entrepreneurship & Partnership Center for Water Technologies. For his accomplishments in both Mekorot and Kinrot, he received the Cleantech Group’s Innovation Hero Award in April 2013, which recognizes individuals whose commitment, drive and passion have made a tangible difference for innovation in general and specifically for many start-up companies.
Previously, Mr. Barnea served for four years as director of business development at Comverse, where he also co-chaired the Mobile Marketing Association.
A unique highlight in Assaf’s story is his former stint as a college basketball player at New Jersey’s Seton Hall University, where he won the Big East championship against Georgetown. He went on to play professional basketball in Israel’s national league, while completing multiple academic degrees.
A certified lawyer, Mr. Barnea holds both law and business degrees from the Interdisciplinary Center in Herzelia, as well as a BA in political science and psychology from Tel-Aviv University.
Dr. Eran Toledo
Dr. Eran Toledo, is an experienced executive, with a strong background in both academic research and industrial development projects. Prior to joining Sanara Ventures, Eran was VP Research and Development with Aspect Imaging, a well-established startup in the field of MRI, with applications in diagnostic medicine, pre-clinical research, food industry and the oil industry. Earlier, Eran was VP Research and Development with Biological Signal Processing (BSP), a startup that developed a novel marker of ischemic heart disease based on a unique approach to ECG signal analysis. Before joining the private sector, Eran was a Fulbright scholar at the University of Chicago, where he focused on developing quantitative imaging techniques in the field of cardiology. Eran also served as a research officer in the IDF Signal Corps.
Eran is a graduate of the distinguished Talpiot program. He holds a BSc in Physics and Mathematics from the Hebrew University and a PhD in Medical Physics from Tel Aviv University. He has over 10 years of managerial experience in the medical device industry and extensive academic research experience. Eran has authored and co-authored over 35 scientific publications and is the inventor and co-inventor of several medical device patents.
BG (RET) Dr. Daniel Gold
Brigadier General (Ret.) Dr. Daniel Gold is Head of Israel’s Defense Research and Development Directorate (DDR&D- MAFAT) at Israel Ministry of Defense (IMOD) and Israel Defense Forces (IDF) since July 2016. Dr. Gold is in charge of determining the defense research and development policy for Israel, including oversight of its execution. He is in charge of all R&D, technology infrastructure, full-scale development, capabilities development including special directorates (Space, UAVs, Missiles/Rockets Defense).
Dr. Gold holds two PhDs which he unprecedentedly completed concurrently within a period of two years: a PhD in Electronic Engineering and a PhD in Business Management, both from Tel-Aviv University. He has held several positions within IMOD and the Israel Air Force including management of IMOD and IDF's main key projects such as Head of IMOD/IDF R&D unit, Head of the main UAV/Drones projects, Head of Electronics & Electronic Warfare and Head of Armament & Avionics Divisions.
Dr. Gold also founded the “Gold R&D Technology and Innovation LTD” company which offer both consultancy and business-technology ventures and development. In addition, Dr. Gold was Head of the Israel National Committee for Commercial/Civilian Cyber R&D and is a board member of Israel Brain Technology Organization. In 2012 Dr. Gold was awarded the prestigious National Defense Prize for his initiation and management of the “Iron Dome” missiles/rockets defense system which made its first operational interception just 3 years after program launch.
Under his leadership, the R&D unit has been awarded the National Defense Prize 12 times.
He is a four-time recipient of the Israeli Air Force Prize, a recipient of the Singapore Defence Technology Distinguished Fellowship Award and in 2012 was selected “Man of the Year” by Forbes Magazine-Israel.
Dr. Gold was honored to light the torch during the opening ceremony of Israel’s Independence Day in 2015.
In a national competition on the occasion of Israel’s 70th Anniversary set by the Ministry of Economy and Industry, the Iron Dome – founded by Dr. Gold – was selected as “The Most Innovative Israeli Technology” of all times since the establishment of the state of Israel.
The most recent achievement was the initiation of Israel’s National Technology Center for the Combat against the Corona epidemic. Under Dr. Gold’s leadership this center, and the various ventures coordinated at a national level, combined the defense R&D, academy, industry, start-ups and medical communities to focus the efforts which made a significant contribution to Israel’s success in helping the medical staff while limiting the extent and severity of the epidemic, enabling the gradual return to routine which is currently under way.
Dr. Angela Irony
Angela Irony (PhD, MPH, RN) is the Executive Director of Sharon District at Maccabi Healthcare at Maccabi HealthCare Services.
In the last decade she performed senior management positions in Maccabi's headquarters as a co-founder and manager of the telehealth center and as the Chief Nursing and Medical Centers Officer.
Angela has led some innovative ventures concerning telecare and remote monitoring for various populations (e.g. pregnant women, chronic patients, etc). As well, she has led significant strategic programs: "Integration 3600" and "Home Hospitalization, "My Pediatrician" app and more.
Fighting Covid19 she has launched the initiation of remote services for managing and monitoring covid19 patients as well as representing Maccabi in the national forum of struggling the pandemic.
Furthermore, as the executive director of the Sharon district she executes the complex yet successful vaccination project reaching compliance rate of 80%.
Angela is a requested lecturer in universities and colleges. She developed an academic course "Advanced technologies in remote medical services" regarding the implementation of various technologies in current healthcare.
Angela is a mother of two sons and is a nurse by profession.
Michel CALMON holds a Doctorate in Law and is also a graduate of the Bordeaux Institute of Political Studies and the National School of Public Health. After having served as deputy director at the Bordeaux University Hospital (1984-1989), then as deputy to the General Delegate of the Fédération Hospitalière de France (1990-1997), he directed the Center Hospitalier de Chartres for ten years (1998-2007), then for four and a half years the Regional Hospital Center of La Réunion, which he led the transformation into University Hospital (2007-2012). After having exercised for three years the functions of General Councilor of health establishments at Social Affairs General Inspection (2012-2015), he has been Director General of the Fondation Santé Service since April 2015. He also assumes the functions of Vice-President of FNEHAD (National Federation of hospital at home).
Treaty on Medical and Hospital Law (Lexis-Nexis Editions): fascicles on the hospital public service, hospital doctors, hospital organization and management
Prof. Michael Montalto
Associate Professor Michael Montalto graduated from medical school at the University of Melbourne in 1986, and completed his PhD there in 1999 on measuring quality in Hospital in the Home care. He has been involved in policy, research and clinical leadership in the area of Hospital in the Home since 1993. He is currently the Unit Head of Hospital in the Home at Epworth Healthcare. He has previously been the Head of Hospital in the Home at Mornington Peninsula Hospital and the Royal Melbourne Hospital, and has been directly involved in the management of approximately 25,000 HIH admissions. Over the last 6 years, he has been involved as a Director of Aged Care Imaging, a mobile Xray service for elderly residents of RACFs. He was successful in obtaining a CMBS rebate for mobile Xray services in RACFs from MSAC, and this commenced in November 2019.
He is the author of over 35 peer reviewed publications, and author of a book. He has been a member of the steering committees of both major evaluations of Hospital in the Home in Victoria, and is currently an executive member of the Australasian Hospital in the Home Society. He is a founding Co-Convener of the World Hospital in the Home Congress, which held the first international meeting of Hospital in the Home in Madrid in 2019.
Prof. Elazer Edelman
Prof. Edelman holds tenured faculty appointments in the Department of Medicine at Harvard Medical School, and in the Division of Health Sciences and Technology at the Massachusetts Institute of Technology. He is the director of the Harvard-MIT Biomedical Engineering Center and of MIT’s Clinical Research Center, and the current occupant of the Edward J. Poitras Chair at MIT.
Elazer Edelman received Bachelors and Masters Degrees in Electrical Engineering from the Massachusetts Institute of Technology, an M.D. degree with distinction from Harvard Medical School, and then his Ph.D. in Medical Engineering and Medical Physics from the Massachusetts Institute of Technology. He is board certified in Internal Medicine, and in Cardiovascular Medicine, and currently serves as one of the Core Attending Physicians in the acute coronary care unit at the Brigham and Women’s Hospital of the Harvard Medical School.
His research interests combine his scientific and medical training. His laboratory has earned international recognition in investigation, diagnosis and treatment of various cardiovascular diseases. He and his laboratory have pioneered basic findings in vascular biology and the development and assessment of biotechnology especially at the interface of tissues, devices and materials and in particular imaging in cardiovascular disease and fusion imaging. Most recently he and his students have focused on machine learning and artificial intelligence in the diagnosis and prognostication of critical diseases like aortic stenosis.
Dr. Edelman also directs the Harvard-MIT Biomedical Engineering Center, dedicated to applying the rigors of the physical sciences to elucidate fundamental biologic processes and mechanisms of disease. Many of his findings are now in clinical trial validation. Almost 350 students and postdoctoral fellows have passed through Dr. Edelman's laboratory enabling publications of numerous papers and patents. He is fellow of the American College of Cardiology, American Heart Association, Association of University Cardiologists, American Society of Clinical Investigation, American Institute of Medical and Biological Engineering, and the American Academy of Arts and Sciences, National Academy of Medicine and National Academy of Engineering and National Academy of Inventors. As Chief Scientific Advisor of Science: Translational Medicine, FDA Science board member and board member of KidneyX he has set the tone for the national debate on translational research and innovation.
Judge: Prof. Pinchas ("Pinny") Halpern
- Trained in Diving and Hyperbaric Medicine at the Israeli Navy Diving Medical Institute, in Intensive Care at Rambam Hospital and at Ohio State University. Was Chair, Emergency Department, Tel Aviv medical Center 1993-2019.
- Associate Clinical Professor in Emergency Medicine, Tel Aviv University, Visiting Professor University of Eastern Piedmont, Italy, and Staff Member of the European Master of Disaster Medicine.
- Past President of the Israeli Association for Emergency Medicine. Member of the Magen David Adom Board of Directors and Chair of the Medical Advisory Committee.
- CMO Sanara Ventures, Medical Director Diagnostic Robotics.
Dr. Mark Davies
Mark joined IBM as Chief Medical Officer for Europe, Middle East and Africa in 2018. He has over 20 years' experience as an NHS General Practitioner in West Yorkshire, UK. He has a long-standing interest in informatics, health policy and system redesign and this has led him to work nationally for 15 years in a number of clinical leadership roles at the Department of Health, Cabinet Office and, most recently, as executive medical director of the NHS Digital.
Mark led an initiative with the US government on common data and health technology standards which led to a landmark agreement between the UK and US governments. He led the health transparency initiatives from cabinet office which led to some of the largest open data initiatives in the world. He was European Medical Director of the global health informatics specialist MedeAnalytics between 2014 and 1027 specialising in population health. He chaired the health analytics committee within the industry group TechUK.
In 2003 he founded one of the largest social enterprise providers in the UK – Local Care Direct, which developed an early model of integrated urgent care using multi-professional groups which continues to cover a population of 3 million people. He is a non executive director of the British Medical Journal.
Prof. Sergio Pillon
MD, Specialist and Fellow in Vascular Medicine, eHealth Master degree, European Fellow of Excellence in Vascular Medicine/Angiology, Member of the board of VAS, scientific association of Vascular Medicine and European Public Health Association EPHA digital health Working Group VAS Representative.
Digital Health Expert of Italian National Health Institute, ISS, TISP Center, Associate Researcher of CNR-ICAR, Italian National Research Council, Medical Director of CIRM, Centro Internazionale Radio Medico.
Coordinator of Digital Health Transformation at ASL Frosinone, Lazio Region, Former CNR (Italian National Research Council) Researcher on telemedicine and peripheral vascular adaptations to the extreme environments (Antarctica, Mount Everest).
Co-Founder and Professor in the first e-Health European Master’s degree, (University of Camerino), co-author of Italian National Telemedicine Guidelines (2014 Ministry of Health) and Chilean Telemedicine and Telehealth Guidelines (2019). Former coordinator of Telemedicine national Committee.
Amrinder Singh joined Medtronic Ventures in 2017. In this role, he supports new investments in the medical device, diagnostics, and healthcare services & solutions space as well as supporting portfolio companies operationally and at the board level.
Prior to joining the team, Mr. Singh led Business Development & Strategy for Medtronic’s services & solutions businesses across the Americas & EMEA regions where he focused on developing and implementing value-based health care strategies for the organization. Prior to that Mr. Singh was with the Medtronic Corporate Strategy group.
Before joining Medtronic, Mr. Singh held Product Management and Engineering positions at Thoratec Corporation, a leading medical device company focused on late stage heart failure.
Mr. Singh graduated from University of California, Davis in Biosystems Engineering, and earned his MBA from Northwestern University, Kellogg School of Management.
Victor Savevski is Chief Innovation Officer and AI Center Director at Humanitas. He is also Adjunct Professor at Humanitas University in Artificial Intelligence and Digital Health Systems in Medicine.
As Chief Digital Officer in Humanitas, he has launched over 50 digital health products, health media platforms, websites, apps and digital therapeutics. Currently being used by over 90 millions users. Starting up and managing a large team of developers, web managers, marketers and project managers to digitalize and grow the digital presence of the hospitals, university and research centers.
Now leading the Humanitas AI Center, focused on research and development on Clinical Applications based on Artificial Intelligence & Machine Learning. Collaborations on numerous A.I projects developed with our team of data scientist, doctors and radiologists together with international institutions. Developing and scaling existing and patient facing digital health products.
Victor is also a contributor for Wired and holds a Medical Engineering degree, a Master of Health Management from SDA Bocconi and a Digital Strategy from Harvard University.
Michal is the Co-Founder and Managing Partner of Triventures and brings over 25 years of experience in medtech and digital health in Israel and the U.S. She co-founded Triventures in 2010 to provide what was then missing in the ecosystem- a deep understanding of commercial integration of innovative technologies into the healthcare system. Triventures was one of the first funds in to focus on digital health in Israel and Michal was the first woman to found and manage a venture capital firm in Israel. Since founding Triventures, Michal has grown the fund into a multi-stage investment platform and industry leader.
Prior to launching Triventures, Michal served for many years in the healthcare start-up ecosystem and held multiple executive positions with GI View, Advanced Stent Technologies (acquired by Boston Scientific), ByPass, TriReme Medical (IPO) andothers. Michal ran several business departments from operations to regulatory and marketing and helped scale and steer the companies towards successful exits.
In 2017, Michal was recognized as one of the 50 most influential women in Israel by Globes, Israel’s leading financial journal and in 2011 she was recognized as one of the 40 most promising leaders in Israel by The Marker, Israel’s leading business journal. With a hands-on approach, Michal is involved in all the fund’s major decisions, leads investments and serves as an active board member in the majority of the portfolio companies.
Dr. Galia Barkai
Professional Experience: Since October 2020 Galia is Director General of Sheba BEYOND, Israel’s first virtual hospital. Since 2018, she has been serving as the director of the Pediatric Infectious Disease Unit as well as the head of the Telemedicine innovation hub, ARC. Previously in 2018, she became part of Sheba's management team as a medical administration intern. Before that Galia worked at Sheba as a consultant for pediatric infectious diseases and as a senior physician in the pediatrics department.
Medical training: Galia completed her training in Pediatrics at the Kaplan Medical Center in Rehovot, and specialized in Infectious Diseases at the Soroka Medical Center in Be'er Sheva.
Education: Galia holds an MD and MBA (with distinction) with a specialization in health systems management from the Tel Aviv University. She completed the Inbar Healthcare Management Program, a joint venture of The MAOZ organization with Israel's Ministry of Health.
David Levine, MD MPH MA, is a practicing general internist and clinician-investigator at Brigham Health and Harvard Medical School. He is active in clinical and translational research through a focus on optimizing quality time at home by shifting care home, decentralizing care, digital health technology, and measuring the quality and experience of health care. He is medical director for strategy and innovation for the Brigham Health Home Hospital and co-chair of the Hospital at Home Users Group. He sees his role as helping patients achieve the right care at the right time in the right place by designing, implementing, and evaluating innovative interaction spaces among a care team, technology, caregiver, and a patient.
David received his undergraduate degree from Pomona College in biology and politics. He earned his masters in teaching in special and secondary science education and served as a high school chemistry teacher and science department chair in Chicago Public Schools. He received his medical degree from Washington University in St Louis and completed his residency at New York University and Bellevue Hospital in internal medicine – primary care. He completed a general internal medicine fellowship at Brigham Health and Harvard Medical School and received his masters in public health at the Harvard School of Public Health.
Lisa is the Chief Innovation Officer for the Henry Ford Health System. She has successfully created and driven the institution’s agenda for leveraging technology, intellectual property, and clinical expertise – all designed to improve patient care, create value for the institution and its partners, and foster economic development. She led the System’s successful entry into international markets by developing a resilient business model, identifying high performing partners, and managing rigorous analyses of business and legal issues such as foreign corrupt practices. Projects in the Middle East and India have created a future revenue pipeline of over $250 million. She also leads the Global Technology Program for U.S. health systems to partner with early stage companies in the U.S., Israel and India.
Lisa has been a serial entrepreneur and strategic advisor to universities and hospitals. Additionally, she raised and served as General Partner (GP) for an investment fund which was successfully deployed to create real estate development around universities. Earlier she rose the ranks of the University of Pennsylvania transitioning from business development, innovation, and executive positions. She began her career at the public accounting firm of Coopers & Lybrand.
Lisa is a collaborator, mentor and inspired business partner committed to the highest ethics as a cornerstone of corporate resiliency. She holds Masters degrees in Government Administration (MGA) and International Relations (MA) from the University of Pennsylvania, and Bachelor’s degree from University of Michigan.
Joe has over 23 years of experience in healthcare, covering technology deployment, management consulting, founding two successful businesses in the sector and subsequently five years of investing. He joined Octopus Ventures as Partner in January 2021, with the intention to launch a new £100 million institutional global fund to invest in early-stage healthtech businesses. With a lifelong passion for healthcare and technology, Joe previously launched TenX Health on the back of leading Google Health in the UK and the Ventures and Healthcare practices for EY in the UK. At EY, he was the global healthcare supply chain leader, ran a UK team of 120 healthcare specialists and founded and jointly led three technology businesses in the UK NHS. Joe has led some of the most significant and high profile transformation programmes in UK healthcare – for example a four year / £14bn programme to transform the NHS supply chain. Joe is a Board Trustee of the Royal Society of Public Health.
Prof. Daniel Lasserson
Dan Lasserson is Professor of Acute Ambulatory Care at the University of Warwick, working clinically in the Acute Hospital at Home services for Oxford University Hospitals NHS Foundation Trust and Sandwell and West Birmingham NHS Trust. He is a founder member of the UK Hospital at Home Society. He has previously worked in primary care as well as his current role in hospital medicine and is the Theme Lead for Acute Care Interfaces in the NIHR Applied Research Collaboration (ARC) West Midlands. He is also Theme lead for Acute Ambulatory Care in the NIHR Community Healthcare MedTech and In-Vitro Diagnostic Cooperative (MIC). He is the chief investigator of an NIHR Policy Research Programme study examining the optimal acute medical care delivery model during winter and waves of COVID-19. He leads the NIHR STOPAPE trial on the management of sub-segmental pulmonary embolism and also works on the NIHR CONDOR study, examining point of care tests for COVID-19 and AVID-CC, a Wellcome Trust Therapeutics Accelerator funded trial examining how a TNF antibody could improve outcomes for patients in care homes with COVID-19. His work for the Society for Acute Medicine includes leading its national hospital benchmarking audit (SAMBA), sitting on the Society for Acute Medicine’s Research Committee and being a member of the Editorial Board of the Acute Medicine Journal.
Dr. Ronald Whelan
Dr Ronald Whelan is Chief Commercial Officer of Discovery Health. A medical doctor by training with an MBA, he was Associate Partner at McKinsey from 2006 to 2013 during which time he co-led McKinsey’s healthcare practice across sub-Saharan Africa.
From 2013 to 2019 he was Partner and Head of Healthcare Investments at Spinnaker Growth Partners where he led investments and business development across a range of healthcare ventures and was founder of Healthforce, a leading telemedicine player in South Africa.
Dr Whelan has extensive experience in clinical and corporate healthcare spanning more than 20 years and 25 countries globally.
Prof. Axel Radlach Pries
Education, professional career
1979 Medical examination, University of Cologne
2/1980 Doctoral degree (Dr. med., summa cum laude)
1980 Postdoctoral Fellow, University of Cologne
1985 Research Assistant (C1), Dept. of Physiology, FU
7/1990 Habilitation, Medical Faculty, Freie Universität Berlin (FU)
1991 Lecturer of Physiology (C2), Dept. of Physiology, FU
1995 Associate Professor, Dept. of Physiology, FU
1997‐1998 Senior Physician, Anaesthesiology, German Heart Centre Berlin (DHZB)
12/1998 Full Professor, Dept. of Physiology, FU
1984‐2014 University of Arizona, Tucson, Consultant for NIH grants with Tim Secomb, (yearly stays of one month at UofA).
2001‐2015 Head, Institute of Physiology, Charité ‐ Universitätsmedizin Berlin
2003‐2015 Board Member, Faculty of Medicine, Charité ‐ Universitätsmedizin Berlin
2008‐2015 Vice Director, Centre for Preclinical Medicine, Charité
2009‐2013 Vice Director, Centre for Cardiovascular Research, CCR, Charité
2015‐present Dean, Charité ‐ Universitätsmedizin Berlin
2018‐present CEO (interim) Berlin Institute of Health (BIH)
Honours, Awards, Fellowships
1980 Thesis Award “Hochhausstiftung”, University of Cologne
1986 Abbott Microcirculation Award, European Society for Microcirculation
1995 Lafon Hemorheology‐Microcirculation Award, International Society for Clinical Haemorheology
2000 Fellow, European Society of Cardiology
2008 Visiting Fellowship, Isaac Newton Institute for Mathematical Sciences, Cambridge/UK
2008 Award of the Asian Union for Microcirculation
2011 Malpighi Award, European Society for Microcirculation
2015 William Harvey Basic Science Lecture and Silver Medal, European Society of Cardiology (ESC)
2015 Kitanomaru Award, 10th World Conf. for Microcirculation, Kyoto, Japan
2018 Poiseuille Gold Medal, International Society of Biorheology
Editorial boards - Cardiovascular Research (associate editor 2012‐2018); Journal of Vascular Research; Microcirculation; Pflügers Archive European Journal of Physiology; Biorheology; PLoS Computational Biology; The Keio Journal of Medicine, Journal of Cardiovascular Medicine; Frontiers in Vascular Physiology, Frontiers in Computational Physiology and Medicine; Bulletin of the Portuguese Society of Hemorheology and Microcirculation.
Leading Functions in Scientific Societies
European Society of Cardiology (ESC)
Congress Programme Committee - Basic Science Coordinator 2005‐2010; 2012‐2014
Council on Basic Cardiovascular Science (CBCS) - Nucleus 2004‐present
Chair - 2010‐2012
Frontiers of Cardiovascular Biology (FCVB), Chairperson 2010
Working Group on Coronary Pathophysiology and Microcirculation - Nucleus 1994‐2002; 2007‐2012; 2014‐2018
Chair - 1998‐2000
CardioScape - Scientific Committee 2012‐2014
Chair - 2015‐present
European affairs committee - 2014‐2016
Advocacy committee - 2016‐present
Alliance for Biomedical Research in Europe - 2016‐present
Member of the Board of Directors - 2017
President - 2018‐2019
International Union of Physiological Societies (IUPS)
Commission on Microcirculation and Capillary Transport Physiome and Bioengineering Committee - 2004‐2010
European Society for Microcirculation (ESM) Strategy committee - 1995‐1998; 2011‐2015
General Secretary - 1998‐2011
International Liaison Committee for Microcirculation (ILCM) Member - 200‐2006; 2015‐present
Chair - 2006‐2015
German Society for Microcirculation and Vascular Biology Board - 1990‐1994; 2011‐2015
General Secretary - 1996‐2011
Conferences (president, co‐president and organization) 6
Symposia (organizer) 46
Member of international scientific program committee 38
Mark Dewhirst, Duke University, Durham, USA; David Boas, Havard University, Cambridge, USA; Klaus Ley, LIAI, San Diego, USA; Tim Secomb, University of Arizona, Tucson, USA; Saul Yedgar, Hebrew University, Jerusalem, Israel; Valentin Djonov, University of Bern, Switzerland; Ferdi le Noble: KIT Karlsruhe, Germany.
Selected Major Publications (H‐Index: 52, Citations > 10000)
CardioScape mapping the cardiovascular funding landscape in Europe.Pries AR, et al. European Heart Journal 2018; 39(25):2423‐2430.
Coronary microcirculatory pathophysiology: can we afford it to remain a black box? Pries AR and Reglin B. European Heart Journal 2017 Feb 14;38(7):478‐488.
Coronary vascular regulation, remodelling, and collateralization: mechanisms and clinical implications on behalf of the working group on coronary pathophysiology and microcirculation. Pries AR, et al. European Heart Journal 2015; 36(45): 3134‐3146.
Making microvascular networks work: angiogenesis, remodeling, and pruning. Pries AR and Secomb TW. Physiology (Bethesda) 2014; 29(6): 446‐455.
Precapillary oxygenation contributes relevantly to gas exchange in the intact lung. Tabuchi A, Styp‐Rekowska B, Slutsky AS, Wagner PD, Pries AR*, Kuebler WM* (*these authors share senior authorship). Am J Respir Crit Care Med 2013; 188(4): 474‐481.
Pulsatile shear and Gja5 modulate arterial identity and remodeling events during flow‐driven arteriogenesis. Buschmann I*, Pries A*, Styp‐Rekowska B et al (*these authors contributed equally). Development 2010; 137(13): 2187‐2196.
The shunt problem: control of functional shunting in normal and tumour vasculature. Pries AR, Hopfner M, Le Noble F, Dewhirst MW, Secomb TW. Nature Rev Cancer 2010; 10(8): 587‐593.
Remodeling of blood vessels: responses of diameter and wall thickness to hemodynamic and metabolic stimuli. Pries AR, Reglin B, Secomb TW. Hypertension 2005; 46(4): 726‐731.
The endothelial surface layer. Pries AR, Secomb TW, Gaehtgens P. Pflugers Arch 2000; 440(5): 653‐666.
Design principles of vascular beds. Pries AR, Secomb TW, Gaehtgens P. Circ Res 1995; 77(5): 1017‐1023.
Resistance to blood flow in microvessels in vivo. Pries AR, Secomb TW, Gessner T, Sperandio MB, Gross JF, Gaehtgens P. Circ Res 1994; 75(5): 904‐915.
Blood viscosity in tube flow: dependence on diameter and hematocrit. Pries AR, Neuhaus D and Gaehtgens P. Am J Physiol 263: H1770‐H1778, 1992. Blood flow in microvascular networks ‐ experiments and simulation. Pries AR, Secomb TW, Gaehtgens P and Gross JF. Circ Res 67: 826‐834, 1990.
Red cell distribution at microvascular bifurcations. Pries AR, Ley K, Claassen M and Gaehtgens P. Microvasc Res 38: 81‐101, 1989.
Aviv Shoher is the CEO of Ichilov Tech, the innovation company of the Tel-Aviv Sourasky Medical Center.
He served as CEO and founder of five startup companies in Israel and in the US and, in addition to scouting out new technologies on behalf of RAD and UIC’s Office of Technology Management, he served as Director of Business Development at Captek and as Senior Vice-President of Business Development at Yissum – Hebrew University.
Aviv earned his MBA with a focus on Health Enterprise Management from Northwestern University’s Kellogg School of Management. In addition, he holds a Law degree, magna cum laude, and a BA in Economics from Tel Aviv University. He is a member of 8400 – The Health Network and of the FHIR-IL leadership team.
Judge: Dr. Irit Yaniv
Dr. Yaniv has more than 25 years of experience in the venture capital, pharmaceutical and biotech industries. As a senior manager, skilled physician, and experienced board member, she possesses a highly developed combination of leadership, decision making and business skills. Dr. Yaniv has served as partner at Accelmed since 2012. During this time, she led Eximo from pre-clinical development through acquisition.
Dr. Irit Yaniv previously served as Executive Director and Chairperson of Accelmed's Innovation Hub portfolio companies. A global group of funds investing and acquiring control in HealthTech companies focused on Buyout and Non-Control transactions in commercial stage companies.
Dr. Yaniv holds an MD degree from the Ben-Gurion University and an MBA from the Recanati Business School at Tel Aviv University.
Internal Medicine specialist. President of the Spanish Society of Hospital at Home. Head of the Home Hospitalization Service, Torrejón University Hospital. Coordinator of the Hospitalization and Telemedicine Working Group of the Spanish Society of Internal Medicine. Coordinator of the Spanish Home Intravenous Antimicrobial Therapy Registry. Member of the Steering Group of the national strategic plan for Home Hospitalization 2020. Master in Management of Clinical Units. University Expert in Health Management. Author of books and national and international publications. Speaker and moderator in forums and scientific events. Tutor at the Francisco de Vitoria University. Director of several postgraduate training activities.
Amir is the Chief Digital Officer for Healthcare Israel and leads strategic digital health cooperation with countries and international bodies around the world. He manages collaboration projects and Government-to-Government (G2G) joint relationships to bring Israel’s E-health solutions and innovations to the world. Key projects include the National Health Information Exchange infrastructure (HIE), open-source EMR application for small clinics, national health-oriented Big-Data research platform, national B2B\B2C Telemedicine platform, and more. Amir has 15 years of experience in IT projects, including 5 years as Program Manager for two national IT healthcare programs for Israel’s Ministry of Health (National Emergency Room Program and Electronic Health Records), as well as 3 years managing complex computing projects in the field of national systems.
Avner Halperin is an entrepreneur and executive in the fields of Digital Health and Big Data Analytics. He is Chairman of the Board at EyeControl – winner of the Genesis Award for significant contribution to helping battle COVID-19. In addition, he leads Global ARC and City of Health Innovation for Sheba Medical Center – ranked as one of the Top 10 Best Hospitals in the world. Previously, he was CEO of EarlySense for 15 years - bringing the company from the idea stage to over 1,000,000 patients served. Prior to that, Avner was CEO of Emmunet, VP Marketing at Radcom (NASDAQ: RDCM), and R&D team leader at Eldat Communications (acquired by Pricer(PRIC.ST)). Earlier, he was Department Head of an R&D Unit in the Israeli Defence Forces Intelligence Corps where he won the Intelligence Innovation Award.
Avner earned an M.Sc. in Applied Physics from Tel Aviv University and an MBA from the MIT Sloan Fellows Executive MBA Program. He has been teaching courses on Economics and Entrepreneurship in the Hebrew University of Jerusalem and Tel Aviv University. His research papers and 33 US Patents have been cited over 3,700 times.
Ori is an executive and entrepreneur with over 25 years of experience in the IT, Internet, telecommunications, medical device and digital health. Prior to Medial EarlySign, he was involved in diverse projects related to data modeling, knowledge representation, search and analytics in multiple development, ideation and management roles. He worked with the Department of Defense, software innovation in a medical devices company, was co-founder and CEO in an internet community venture, a co-founder of financial services company, and held VP roles at Pontis, a company involved in Big Data real-time personalized marketing for large network operators (acquired by Amdocs symbol:DOX). Ori is involved in digital health, machine learning and predictive modeling since 2009. Ori holds BS in mathematics and computer science, cum laude, from Bar-Ilan University.
Mr. Vikram Thaploo, CEO – TeleHealth at Apollo Hospitals Enterprise Limited.
With above two decades of experience in diverse industries including healthcare, retail and hospitality, Vikram Thaploo is a veteran of strategizing innovative projects and creating sustainable business models.
Vikram is currently leading Remote Healthcare Practice and Public Private Partnerships at Apollo Hospitals. This comprises of Apollo TeleHealth (Healthcare delivery and TeleClinics Company), HealthNet Global Limited (Healthcare Technology Company) and Apollo Telemedicine Networking Foundation (Not-for-profit Company) along with the government business vertical.
A management professional from Indian School of Business with extensive experience in setting up and scaling up businesses, Vikram has a superior track record in conceptualizing ideas and implementing them for successful business expansion. He is one of the Global names in the field of Telemedicine. His mission is to make healthcare accessible to all using the convergence of Technology, Telecom, and MedTech ecosystems, thus, delivering Continuum of Care. Over the years he has been aggressively working towards elevating Public Health care delivery and Rural Healthcare.
Sumit Singh is a dedicated Technology Executive leader with over 29 years of experience specialising in Healthcare and Finance verticals within the United States, India and UAE. He has a proven record of accomplishment delivering business transformation through strategic and tactical technology initiatives. He has been with VPS Healthcare since spring 2019 as its technology leader, spearheading the technology transformation for the group across various healthcare businesses of VPS globally. Prior to VPS Healthcare, Sumit was Vice President and CIO with Wockhardt Hospitals Limited based out of Mumbai, India for 8 years. Earlier, he was based out of US for 20 years, and after completing his education, started his career there gaining deep understanding of the US financial markets while having worked with various organizations such as Ernst & Young LLP, TD Ameritrade Holding Corp. (now Charles Schwab), OnMoney Inc., Prodigy Services Company (IBM Company) and Clemson University. He has extensive experience in deployment of enterprise wide IT application, infrastructure and of business continuity plans along with continued maintenance and upgrade responsibilities. Over the years, he has been part of some key M&As.
His areas of expertise are:
IT Governance and Execution of large complex IT projects
Deliver customer value, executing strategic plans, while promoting growth and expansion
Full Life-Cycle project management: Conceptualization to Delivery
People Leadership – Building, Managing, Mentoring and Coaching
Vendor/Partner evaluations and management for outsourced projects
He has done his MS in Computer Communications from Clemson University followed by an MBA in Finance from Pace University, both in USA. He also holds a Bachelor’s Degree in Electronics Engineering from Bangalore University. Apart from this, he has attended various leadership programs, received numerous recognitions, and has many certifications in areas of Management and IT.
Besides work, Sumit takes interest in music, light writing, current affairs and leisure travel.
Dr. Aditi U. Joshi
Aditi U. Joshi MD, MSc is a Senior Advisor in Telehealth and Assistant Professor of Emergency Medicine at Thomas Jefferson University Hospital. Her position at TJUH is multi-faceted in telehealth and tele-intake: working in operations, quality assurance, provider training, resident and medical education and implementing new programs and use cases for telehealth. She is director of a Telehealth fellowship aimed at training future physicians interested in leading virtual care. Nationally, she serves as the Chair for the Telehealth committee of the American College of Emergency Physicians, helping expand the role of telehealth within the specialty.
Aviad Tamir is the Head of Life Sciences & Healthcare at Invest in Israel, helping multinationals and investors to establish their operations in Israel. His professional experience spans across Israel and abroad working with Pharmaceutical & Healthcare industries, specializing in International Business Development & Strategic Partnerships within the private and public sectors. Previously, Aviad worked at the Ministry of Defense, Mission to the U.S. managing procurement projects for the IDF, and the Office of the Prime Minister as an Advisor to the Director General of the Ministry for Senior Citizens.
Dr. Itai Kela
Dr. Itai Kela is the Head of The Healthtech Sector in the Israel Innovation Authority. Dr. Kela role is to nurture and develop healthtech innovation resources, while creating and strengthening the infrastructure and framework needed to support the healthtech industry and its ecosystem to promote Israel economic growth. In the era of the Covid-19 epidemic crisis, Dr. Kela role is to build Israel national strategic preparedness and response plan to epidemic threats and to define the actions and infrastructures required to stop further transmission of Covid-19 within Israel and in order to be prepared to the next outbreak. Dr. Kela has developed the newly launched strategic program in the Israeli Innovation authority, the "Bio-convergence program", which defined as the next growth engine of the Israeli economy and serve as the scientific director of the Bio-convergence national program. Dr. Itai Kela has over 15 years of experience in leading product development programs, specializing in drug development, cell therapy, immune oncology and genomic based personalized medicine. Dr. Kela proficiency is characterization of market needs and trends to define strategic development path. Dr. Kela has a proven track record of meeting business development targets and led international collaborations with multinational corporations, research institutes and hospitals in the US and Europe. Before joining the Israel Innovation Authority, Dr. Kela held a variety of executive positions in healthtech fastgrowing companies, NRGene, Stem Cell Medicine and Protalix (NASDAQ:PLX). Dr. Itai Kela holds a PhD in cancer genomics and computational biology from the Weizmann Institute of Science and specialized in immune oncology and computational genomics from the Stanford University. Dr. Kela received “The Center of System Biology Award” from the Weizmann Institute of Science.
MindUP is Israel’s leading digital health incubator and a joint venture of Medtronic, IBM, Pitango VC and Rambam Medical Center, and in collaboration with the Israel Innovation Authority. MindUP funds, supports and nurtures early stage innovative digital health ventures.
Dan has been a leader in the global healthcare technology industry for over 15 years, with experience spanning Fortune 500 companies in the U.S. to Israeli startups. Prior positions include CEO and President of Virtual Ports Inc., General Manager (EndoTool Clinical Decision Support Business Unit) and Director of Strategic Marketing for Hospira Worldwide, Inc., and senior positions at Johnson & Johnson (Ethicon and Ethicon EndoSurgery) and LifeWatch, Inc. He also enjoyed a 13-year career as an intelligence officer in the Israel Defense Forces.
Dan holds a Master’s in Business Administration, with Honors, from the University of Chicago Booth School of Business, and a Bachelor of the Arts, Cum Laude, in Economics and Business Administration from the University of Haifa, Israel.
Extensive experience in Life Science investments from seed stage to late-stage due diligence. Works closely with Peregrine’s portfolio companies with management mentoring and support in project management, strategic planning and business development. Prior to Peregrine Lior served as the Deputy Program Director of the Incubators Program. Lior serves on the Boards of Memic, Cordio, Magneto, Restore, Nitinotes, Sinusafe, Magnisity, Endostream. Holds an MBA from the Recanati School of Management - Tel Aviv University and a BA in Economics and Business Management from - University of Haifa.
Tsiel Ohayon has 15 years’ experience in the healthcare industry and over 30 years in the field of Enterprise Software in development and sales. Apart from Israel, Tsiel has lived in several countries including the USA, France, and Japan.
As part of his work in the healthcare industry, Tsiel has worked on enabling several Population Health projects internationally and has worked in many challenging Population Health (PH) projects whether local, regional, statewide or at a national level. He has guided project teams architect PH projects, based on analysis of client requirements, and needs, including the South West Sydney PHN in Australia, Salford Royal Trust and Dudley Trust in the UK PH projects.
Tsiel holds a bachelor’s degree in Computer Engineering from the Israel Institute of Technology, Technion.
Tsiel lives in Netanya, north of Tel Aviv, with his wife of 25 years and two teenage sons.
Experienced Business Development Manager in HealthCare industry with vast knowledge and expertise in Medical Device and Digital Health domains; regulatory and reimbursement environment, country’s business potential assessment, go to markets strategy, marketing, establishing and maintaining extensive partnerships and improving customer experience.
High familiarity, engagement and working relationships with Israeli Start-Ups and HealthCare industry ecosystem (local and global).
Holds a BA in Political Science from Bar-Ilan University, Israel and an M.B.A., with distinction, from Istanbul Bilgi University- Laureate, Turkey
Speaks Turkish, Hebrew and English fluently
Telecommunications Engineer by Alcalá de Henares University.
Medical Studies at the Alcalá de Henares Medical School.
International Marketing at INSEAD Business School.
Currently, he holds the position of Director of Innovation at the Health Care Institute in ESADE Business & Law School and President of Additum Blockchain, a new company that aims to facilitate the market access to companies generating innovation on the fields of bio-medical and digital medicine.
He is also President of the Board at Health in Code company leader in Genetic Diagnostic in Spain, and also member of the European Society of Cardiology.
He recently retired from Medtronic after 25 years as European Regional Vice-president and President of Medtronic Spain, Portugal and France. During his latest years in Medtronic he led the transformation to a solutions company, under the new paradigm of Value Based Health Care.
Previously he served as General Manager at HP Spain Medical Division for 17 years.
He served 20 years as Vice-president of the Spanish Health Care Industry Association (FENIN), 8 years as President of the FENIN Tecnologia y Salud Foundation and he was a member of the Spain-USA Business Council for 6 years.
Currently, he is also member of the HM Hospitals Research Foundation and of the Spanish Federation of Scientific and Medical Associations Foundation (FACME).
He has been part of many articles, books and conferences on the topic of Medical Technology and Health Care Management.
Now his interest is focused on innovation and entrepreneurship in Health Care.
Dr. Anthony Nsiah-Asare
Dr. Anthony Nsiah-Asare (1954) is presently the Presidential Advisor on Health, at the Office of the President of Ghana. Having worked in leadership roles as Medical Superintendent at District hospital, Medical Director at the Regional hospital, Chief Executive Officer at the Teaching Hospital, and Director General of Ghana Health Service, Dr. Nsiah-Asare has created a balance of strategic, operational, business, clinical and health system reform expertise. He is an alumni of the Boston University, School of Public Health in USA where he obtained his Certificate in Management Methods in International Health. He is a Fellow of the West African College of Surgeons (FWACS), Ghana College of Surgeons, (FGCS) and the International College of Surgeons (FICS). He is also a Fellow of Ghana Medical Association. He serves as a Member of the Ghana COVID-19 Taskforce, Ghana’s Vaccine Production Committee, Garden City University College Council and Chairman of the Cosmopolitan Health Insurance Board. He served on the Ghana Health Service Council, the Ghana College of Physicians and Surgeons Council and National Health Insurance Board.
Dr. Anastasia Nyalita
Brilliant, passionate about corporate governance, servant leader and loves taking up new challenging opportunities.
Anastasia Nyalita is a dynamic and competent health specialist and an MBA graduate passionate about sharing her skills and knowledge and contribute to the growth and strategic direction of organization in the healthcare sector.
She has held various senior leadership roles in Policy & Advocacy, business and technical operations in several health organizations and multinationals in the Pharmaceuticals and Consumer Health Sectors over the last 20 years. She has a geographical experience across Sub Saharan Africa and South East Asia countries. These roles have allowed Anastasia to garner invaluable skills and experience in leadership, external affairs, business management, project planning and execution as well as, strong organizational skills.
Anastasia is very active in professional activities with a history numerous leadership positions in professional and trade associations, and has exceptional problem solving and decision-making skills. She is passionate about Leadership and Corporate Governance and has excellent communication skills in English, a working knowledge in French.
She is a certified Corporate Governance, Board Evaluations and Governance Assessments Trainer.
Role: International Key Account & Projects Manager, Philips Health Systems.
Education: MBA , Technion- Israeli Institute of Technology; LLB (Law), The Hebrew University
Work Experience: 9 years of experience in International Business Development on Healthcare and IT Solutions.
2009-2012 Deputy Chief of Mission in Embassy of Israel in Addis-Ababa.
Noa Partuk Eitan
Noa is currently responsible for the Ministry's operations in the UAE and Middle East. Prior to that, she spent 3 years managing the Ministry's operations in Africa, with the goal of promoting the trade, business and knowledge sharing between Israel and African countries. She also liaised and operated the funds and collaborations with the International Financial Development Institutions Israel is a member of, such as the World Bank. Prior joining the Ministry, Noa was spend 3 years in NY, USA and 2 years in Cape Town, SA, developing global Jewish leadership. Noa holds a B.A in Mass Communications and Mass Media from the Interdisciplinary Center, Herzliya, and an MBA from the International Business School of Ben Gurion University.
Dr. Benji Ozynski
Dr. Benji Ozynski is a medical doctor who graduated from the University of the Witwatersrand. He is the Director of Business Development of Wits Healthcare Innovation - the health tech innovation hub of Wits University and a co-founder of Market Mx - a health tech startup increasing patient numbers for private healthcare
practices. He discovered his passion for entrepreneurship after starting his first business in medical school, and is working to build a career integrating business, health and technology.
In his tenure at Wits Healthcare Innovation, he has led multiple implementation projects, built health tech solutions and integrated technology and medical research.
Degree in International Business from La Sabana University in Colombia and an MBA from Anahuac University in Mexico. Over 8 years of experience working in the Life Science sector. Deborah is expert in identifying business opportunities in Mexico for Israeli companies in the health, automotive, advanced manufacturing and consumer goods sector.
Strategic Marketing professional graduated from Yale University with more than 30 years of experience in the medical devices industry. Leading key companies in the US and International markets in the surgical, biologics, vascular access, and IV infusion segments.
Meni has over 15 years of experience working in the Medical Device and Healthcare IT industries. Meni holds a BS in Computer Sciences from Florida Atlantic University and an MBA from the Kellogg School of Management - Northwestern University. Meni spent a decade in a variety of senior roles at Abbott Diagnostics working on their state of the art informatics offering, design and commercialization, as well as in Digital Health Product Management, R&D, and Business Development. Meni also served as the Chief Software Architect for the Abbott Informatics Division. Most recently, Meni spent several years at CareDox, serving as the Chief Product Officer designing innovative Cloud and Mobile platforms to transform pediatrics.
Dr. Dekel Taliaz
Dr. Taliaz is the CEO and Co-Founder of Taliaz, a digital health startup that has developed, PREDICTIX: an AI-driven mental health platform, supporting doctors to better assess, manage and improve prescribing precision for a faster patient recovery. Dr. Taliaz holds a PHD in Neuroscience from the Weizmann Institute of Sciences, and has published numerous, highly cited papers in leading peer-reviewed medical journals and received several honors and awards during his studies.
Naama Perry Cohen
Director of Digital and Technology Innovation Division with the Government Medical Centers Directorate within the Ministry of Health.
The Division headed by Naama is responsible for the initiation, development and implementation of digital technologies for a network comprised out of of 25 medical centers.
The division is also responsible for the field of research, innovation and the regulation of work processes in the largest network of hospitals in Israel.
She has more than 20 years of experience in managing diverse projects, groups and domains in the world of information systems in various global companies.
A proven expert at leading both established as well as fledgling organizations to success, Alon has served as president and CEO of several life-science companies including Apos Medical Assets Ltd., the company behind AposTherapy®, a patent-protected orthopedic medical device, Procognia (TASE: PRCG), a biotechnology company specializing in glycobiology and biopharmaceutical analytics, Brainstorm Cell Therapeutics (NASDAQ: BCLI), a biotechnology company developing innovative, autologous stem cell therapies for neurodegenerative diseases and OHK Medical Devices Ltd., which manufactures and markets innovative products for orthopedic and vascular extremity procedures.
Prior to that, Alon was director of marketing and finance in Teva Pharmaceuticals’ Copaxone division (NASDAQ: TEVA). It was there that he played a key role in the commercialization of patented therapeutics for multiple sclerosis, establishing the division and executing its international strategy and product launch.
Alon holds a B.A in Economics and Philosophy, and an M.B.A in Finance, from The Hebrew University, Israel
Martha Caballero Abraham
She holds a Bachelor's Degree in International Relations from the Autonomous Technological Institute of Mexico (ITAM). She worked at Foreign Affairs magazine in Spanish before joining the Mexican Foreign Service in 2005, when she was named Consul attached to the Mexican Consulate in San Pedro Sula, Honduras.
At the beginning of 2009 she worked in “Grupo Expansión” and, in April of that year, began working in the Ministry of Health of Mexico as Head of International Media in the General Direction of Social Communication. As of March 2010, she was also appointed as Representative of the General Direction of Social Communication for the strategy: “Todos Somos Juárez”.
Since September 2011 she has served as Director of Bilateral and Regional Cooperation and since 2019 has been in charge of the General Direction for International Relations of the Ministry of Health of Mexico.
Dr. Moises Zielanowsky
Graduated from the school of Medicine from the Autonomous University of Mexico. Postgraduate Fellow in Colon, Rectum and Anus Surgery, at the Lahey Clinic Medical Center, Boston, Massachusetts, Dr. Zielanowsky occupied positions such as the Presidency of the Medical Association of the ABC Medical Center, as several positions on the board of directors and reaching President of the American College of Surgeon, Mexico Chapter, also becoming Governor of the American College of Surgeons, Mexico Chapter (6 years) and Head of the Trauma Committee for Mexico (6 years). Since 2019 Dr. Zielanowsky is the Director of the Primary Care Clinic of the ABC Medical Center, Mexico City, “MedCo”. Health Solution for Companies and Medical Advisor for Preventive Medicine of the ABC Medical Center, Mexico City
Ziv Yarshansky serves as Head of infrastructure and IT Operations at Sheba Medical Center.
Previously he held the position of EMEA IT Regional Director for CA Technologies. Ziv brings over 25 years of experience in managing and leading technology groups in global enterprises. He has extensive knowledge in Agile, UX, ITIL Methodologies, as well as in IT infrastructure, Cyber Security, IT regulatory compliance and IT Operations.
Ziv is holding a BSC in computers Degree and Master's degree in business administration (Focus on Information Systems) from the University of Derby, England.
Dr. Ziv Paz
MD MSc MPH MBA is the Director of the rheumatology division and the Chief Innovation Officer (CIO) at the Galilee Medical Center (governmental hospital).
Previously, Dr. Paz was a physician scientist at the Beth Israel Deaconess Medical Center and Harvard Medical School, Boston MA. Dr. Paz received his medical and Master of Science degrees from the Hebrew University Hadassah Medical School and his master of public health degree from the Harvard School of Public Health. Recently Dr. Paz received his MBA degree from Tel-Aviv University. As the CIO, Dr. Paz role is to oversee the implantation of new technologies and promote digital transformation at both the hospital and at the national level. His own research focus is on the usage of big data to improve the ability to prevent complex long term outcomes and morbidity among patients with rheumatic diseases.
HR Director of the Directorate of Governmental Medical Centers within the Ministry of Health.
Lital is responsible for the recruitment, professional training, human capital development, evaluations and the overall management of the human capital for the network of 25 medical centers, and more than 50,000 employees. Lital has more than 20 years of experience in managing HR.
Talor Sax, Founding partner and CEO of “eHealth Ventures” - a leading digital health incubator with a portfolio of exciting and promising start-ups. Holding 20 Years of international experience in leading Digital Health, Healthcare IT, and Healthcare technology companies. Backed by mixed education of Computer Science, Economy, MBA corporate finance.
Experience as CEO, Product Management and Business development of Digital health companies.
Track Record including USA, Europe, India and Israel.
Over 20 years of Entrepreneurship and Management experience in Israel, the USA and Europe in digital medicine companies
Director of Product Management at iMDsoft
Entrepreneur of several start-up companies. Fellow in the Inbar Program for Leadership in the Health System
In 2020 voluntarily founded the Israeli Telemedicine community
Dr. Stephen H. Cohen
Stephen H. Cohen, M.D., is Senior Vice President and Chief Medical Officer of Excellus BlueCross BlueShield. In his current role, Dr. Cohen leads the Medical Services Division at Excellus, responsible for all aspects of member care management, clinical operations, quality and plan accreditation, and the medical director team for all lines of business.
A primary care physician and lifelong resident of Rochester, NY, Dr. Cohen is board certified by the American Board of Internal Medicine and the Certifying Commission in Medical Management. He is also a member of the Monroe County Medical Society.
With over 25 years of Physician Executive experience, Dr. Cohen has been at Excellus BCBS since 2014. His prior roles include utilization management, clinical lead for the Commercial LOB, President of Lifetime Care Home Health Care and Hospice and President of the Lifetime Health Medical Group. He served as Corporate Vice President for Medical Affairs at MVP Health Care, and Vice-President of Clinical Consulting for Relph Benefit Advisors.
After graduating from Albany Medical College, Dr. Cohen completed his residency in primary care internal medicine at the University of Rochester Medical Center and held leadership roles at Highland Hospital and the University of Rochester Center for Primary Care.
Dr. Cohen and his wife, Stephanie, are proud to be the parents of three children and five grandchildren. He enjoys travel, photography, the Finger Lakes, and reading.
Al Kinel is the founder and President of Strategic Interests, LLC, a consulting firm dedicated to transforming healthcare through innovation. Al works with health systems, health plans, long-term care providers, collaboratives, government, and vendors to create a long-lasting, positive impact through the innovative use of IT. Prior to starting Strategic Interests, Al worked for top tier professional services firms and in Technology Management for Xerox and Kodak Health Group. Al is a thought-leader, community activist, and catalyst who excels in the application of digital health solutions. Al is active with several technology associations and think tanks.
Al has served on the boards of numerous Jewish organizations including the Jewish Federation of Rochester, Jewish Senior Life, and is currently the Chairman of the Israel Bonds of Rochester.
Al is active with several startups, including a number from Israel that will change the world. Al enjoys bringing his experiences and relationships together to help them develop strategies, plans and operations in the US - helping Israel increase exports of digital health solutions.
Al received a BS in MIS from the State University of New York @ Albany, and an MBA from the Darden School of Business at the University of Virginia.
Aaron (Nenegliang) Yao
Professor of Center for Health Management and Policy Research, Shandong University;
Scientist in Geriatrics of University of Virginia
Research area: Home-based Medical Care, Elderly Care
Main academic achievement:
Health Care Utilization and Unmet Needs in Chinese Older Adults With Multimorbidity and Functional Impairment. The Journal of the American Medical Directors Association. 2020. https://doi.org/10.1016/j.jamda.2020.02.010 Wang S*, Kim K, & Stokes JE. Dyadic profiles of personality among older couples: Associations with marital quality. Journal of Social and Personal Relationships. 2020. 0265407520916246.
Challenges of home-based medical care in China：a qualitative research from the perspectives of home care clinicians. Chinese General Practice. 2020
Geriatrics, medical and non-clinical services for the study of common diseases of the elderly, especially geriatric tumors, neurodegenerative disorders, geriatric care, such as the application of the debilitating index of the comprehensive assessment of old age in geriatrics and its impact on patient health, the medical and life problems and solutions of elderly cancer patients, and non-medical solutions to behavioral problems of patients with cognitive impairment.
Gerontology, studying the physical, psychological, economic and social impacts of aging on real life, such as the impact of social relations/social participation of older persons on health, family relations and physical and mental health of older persons, long-term care projects and policy assessments, quality assessment of nursing home care, hospice care, transport safety for the elderly, and the construction of elderly-friendly cities.
Home-based medical care, research on how to provide quality and affordable care in the homes of the elderly and weak patients, including home health care effectiveness, quality system, cost-effectiveness, satisfaction, payment system, fairness, education and training, scientific and technological innovation and other issues.
Born in Sept. 1972, Chairman of Beijing CunCaoChunHui Elderly Nursing Home.
Doctor in Social Security of Chinese Academy of Social Sciences;
CPPCC Standing Committee member of Chaoyang district.
Elderly care consultant of Asia Development Bank;
Member of National Committee of Experts on Pension Service;
Member of National Social Welfare Standardization
With extensive working experience, connection and exposure, both in broad international geography (over 30 countries) and diverse healthcare sectors/dimensions (Third Party Accreditation/Consulting Agencies, Public/private hospitals and academic medical centers, large physician group practices, health insurance including HMOs, IT companies, Public Health, Health policy research, etc), Dr. Jilan Liu is credited as one of individuals that have contributed in reshaping the healthcare delivery around the world, and in China through standards/accreditation, patient/staff experience and organizational performances.
As Chief Executive for HIMSS Greater China, Dr. Liu made a significant breakthrough, in a very short timeframe, since 2014, with Chinese Hospitals and HIT industry in the Greater China Region in embracing international HIT standards, certification requirements, and a rethinking and reconsideration on prudent approach to IT investments and operations. She has also successfully led the effort to help organizations transforming healthcare through Information and Technology. This led her committing her recent effort to a broader scope by help launching a new UK based International Journal of Digital Health, as its Co-Editor in Chief.
As JCI Principal Consultant and Director for Greater China Practice until the end of 2017, Dr. Liu has provided consultation services to hundreds of hospitals in around 30 countries in most of the continents in the past 15 years. She has guided her client hospitals around the world, in transforming their clinical and managerial operations toward better patient safety, higher quality, more respect with personalized care and attention, and greater operational excellence.
Vitalerter, is a startup company, engaged in the development, manufacturing and distribution of continuous human body monitoring and protection for long term care patients.
Miki has more than 25 years' experience in applying technological solutions to business opportunity and costumer needs. He has been leading researchers and high-tech teams to creatively solve common problems with original solutions.
Mr. Nahum Ferera is an entrepreneur specialized in leading medical device projects from an idea to commercialization.
Nahum founded EyeYon Medical alongside Dr. Daphna and Dr. Marcovich in 2011 and serves as active CEO. Nahum led the commercialization of EyeYon’s initial product – the Hyper-CL™️ - from an idea to CE approval and FDA clearance.
Nahum has extensive experience in c-level management, ophthalmic medical devices, business development, clinical trials, regulation, and intellectual property.
Prior to EyeYon Medical, Nahum led a project of non-invasive blood glucose monitoring, successful in passing the clinical trials and resulting in a granted patent. His experience includes developing medical devices in the field of cardiac rate management based on MEMS technology.
Additionally, Nahum serves as a mentor for the international MBA at Tel Aviv University at the Israeli bio-executive forum, and as a panelist in the international MBA program at Technion, Israel.
Ferera holds MBA & B.Sc. Eng. in biomedical engineering from the Tel Aviv University, Graduate of the Merage Leadership Seminar for Life Sciences Executives at the University of California, Directors Course at IDC Executive Center and CRA at GCP Academy.
Jeanne Kehren graduated from the Maisons-Alfort Veterinary School and holds a master in Virology from the Pasteur Institute and a PhD in Immunology from the Paris 7 University.
Jeanne Kehren started her career at Novartis, where she worked in different R&D roles and drove the integration of innovative technologies in drug development. She also fostered the integration of large scale data in pre-clinical and clinical investigations and developed biomarker and stratification approaches across different disease areas. She joined Sanofi in 2009 as Project Director and held successive positions in Product Development across different therapeutic areas, bringing together Commercial, R&D and Industrial Affairs teams on some major development projects. After joining the Global Strategic Development group in charge of products and Franchise investment strategies, she took the lead of the Early Assets group for Diabetes & Cardiovascular and Primary Care working on the reshaping of the portfolio and the development of new businesses. Jeanne joined Bayer on July 1, 2019, heading Digital & Commercial Innovation. As of Feb. 1, 2021 she has been appointed Chief Information Officer Pharmaceuticals in addition to her other responsibilities.
Jeanne is French citizen. She is married and has two children
Inon Elroy is a seasoned and professional executive in international economic and technological cooperation, innovation platforms that bring together entrepreneurs, academy institutions and governments. Inon was appointed Economic Minister to North America in August 2016. He has more than twenty years of experience representing the Ministry of Economy and Industry in a wide range of executive positions both in Israel and overseas.
As Vice Director General of the Israel Ministry of Economy and Industry from 2012-2016, Inon was tasked with overseeing industrial policy (promoting domestic production and innovation), trade regulations (liberalization of imports, anti dumping, and standardization), and regional economic planning. In addition, he supervised the Ministry's digital strategy, and initiated policies to foster innovation synergies between the public and private sectors. Inon served as the Economic and Commercial Counselor in France (2001-2005) and Germany (2009-2011). Earlier in his career, he was an advisor to several ministers of Economy and Trade.
Inon served as a board member of the research committee of the Office of the Chief Scientist, which approves industrial R&D projects. He was also Alternate Director for the bi-national R&D funds BIRD(US-Israel), SIIRD (Singapore –Israel), and KORIL (Korea-Israel). Additionally, he served on the boards of the Israel Wine Institute and the Israel Consumer Council.
Inon holds an MBA from the University of Haifa and a BA degree in Political Science and Geography from the Hebrew University in Jerusalem.
Uri Gat-Palash currently serves as the managing director of S.L.E leading an operation that manages over 10,000 products and provides orders to 4,000 endpoints through many diverse segments at different frequency, while complying with the strictest standards such as GMP / GDP and Israeli Ministry of Health regulations.
Uri has been with Teva over 15 years during which He has served in multiple positions, including Director of Trade Activities in the API Products Division for Europe and Director of Business Development for Teva in the Indian Market.
Uri holds a BA in Economics & Business Administration and an MBA specializing in Finance and Marketing from the Hebrew University of Jerusalem
Senior-level professional Entrepreneur experienced as CEO, Vice President and GM of public and private Healthcare IT companies for 17 years.
Highly analytical decision-maker with extensive experience in building, turning around, and operating healthcare businesses, along with proven history of increasing productivity and turning around difficult situations.
Seasoned executive with in-depth understanding of evaluating emerging technologies and their commercial applications, as well as international business expertise, having conducted business in Europe, Asia, and North America.
Founder and CEO of Maverick Medical AI - Maverick develops the first commercially trained deep neural learning network based on big data of real sub-specialized clinical data. Our Clinical AI Cognition™ Platform understands and converts the unstructured text of patient reports to valuable medical codes, providing a single platform automating the medical coding process for payers and providers across all care settings.
Independent consultant in Healthcare IT, Medical Imaging - Specialties: Medical Imaging (PACS, RIS, CPACS & Imaging workflow) Experienced in the latest cutting-edge technology related to Imaging analytics such as Machine learning and Artificial intelligence.
ZEBRA Medical Vision – VP, Sales & Business Development - Responsible for Zebra Global Sales and Business development o Developed the international business growth and strategy. o Evaluating partnerships with global healthcare companies.
2013 - 2016
McKesson Corp - Executive Director, UK & International - Responsible for McKesson’s Imaging international direct and distributor business – acting as the company GM in the UK o Developed the international business growth and strategy. - Led the Product Management team outside of North America to understand specific localized requirements- Created a new vision and strategy of products that can differentiate McKesson from competition - Managed multiple P&L’s over different countries - Responsible for International business development. Evaluating new products and technologies to be embedded to the McKesson product.
2011 – 2013
McKesson Corp - Director, Product Management and International Business Development - Identified and analyzed the business opportunity for international markets. - Responsible for International Business Development for the Medical Imaging Group (including Cardiology, Radiology and Electronic Document management system products). - Adaptation of existing products in the North American market to other markets such as Europe and Asia Pacific. - Building Business Development Plans to launch McKesson's products to new markets such as Great Britain, Japan, Germany and Brazil.
2009 - 2011
McKesson Corp - Manager of Product Management - Managing a team of employees - Examining the profitability of the International Markets and technologies in which McKesson's operates.
Medcon, Ltd & McKesson Tel-Aviv, Israel Product Manager for Cardiology Imaging - Managing a team of system engineers. - Integrated two different product lines (cardiology and radiology) of two different companies (Medcon and Mckesson) and developed a new product line that answered the markets' demand. - Designed and developed McKesson’s ECG management system from early stage of idea through FDA acceptance and product release.
2008 - 2009
Kellogg & Tel Aviv University - Executive MBA
Izrael Valley Academic College: Bachelor of Computer Science (B.A degree) – Major: Information systems May 2001, MCSD.
Hebrew – Mother Tongue English - Mother Tongue Level
(1993-1990) First Sergeant in the IDF Navy. Naval Medic. Served as a weapon guidance commander
Hilla Shaviv is a biomedical engineer and a serial entrepreneur in the women's health arena, with more than 20 years of experience in medical device R&D, the last 13 years she focused on researching and developing women's health devices. Hilla studied bio-fluid dynamics focusing on developing a heart assist device, as well as carrying out computational blood flow and in-vitro simulations.
Hilla earned a BSc from Caltech (Mechanical & Fluid Dynamics Engineering, cum laude) and an MSc from Tel Aviv University (Biomedical Engineering).
An experienced leader in the high-tech ecosystem, Yair’s strong technical background combined with his global business expertise has driven exceptional business growth in numerous companies. A senior veteran with the 8200-Unit (Intelligence Corps), Yair served in multiple C-level positions with companies such as Enabley, Edvantage, Pontis and Amdocs. Yair earned his MBA from the Recanati Business School at Tel Aviv University and a B.Sc. in Engineering (Information Systems and Industrial Management) from Ben-Gurion University.
Dr. Doron M. Behar
Dr. Doron M. Behar, CEO, Igentify holds an MD and PhD degrees from the Technion - Israel Institute of Technology. At his capacity as an MD he graduated two specialization programs in Internal Medicine and Critical Care Medicine in Rambam Medical Center, Haifa Israel and a third specialization program in Medical Genetics at the Raphael Recanati Genetics Institute, Rabin Medical Center, Beilinson Campus. In parallel, his PhD thesis was in the field of Population Genetics. Dr. Behar's research area of interest is across the broad range of evolutionary genomics, ancestry, phylogenetics and translational genomics.
Dr. Behar has multi-year background experience in the development of genetic testing for the public using a direct internet based customer approach at his capacity as the chief medical officer of Gene by Gene Ltd. During the course of his work he gained expertise in in the various aspects of mass genotyping, including regulation, privacy, database creations and mining, website designs, automation, machinery, genetic analysis, quality reassurance, and more. His primary interest is in developing robust, low-priced genetic testing to the general public that will allow the hope of responsible personalized genetic medicine to any individual worldwide.
Since June 2016, Mr. Ropiecki has served as Executive Director of Care Compass Network and led the New York State healthcare transformation initiative under the DSRIP program, aiming at reducing avoidable services, integrating care, and reducing overall spend in the Southern Tier region. Mr. Ropiecki has been instrumental in convening and collaborating with hospital systems and community-based leaders throughout a largely rural nine-county region representing 1/8th of NY. He has overseen the development of healthcare reform implementation and been a catalyst for innovative funding programs that support community-led initiatives integrated with clinical services and deployed over $135M in resources throughout the community.
Prior to CCN, Mr. Ropiecki was a member of the Deloitte & Touche Healthcare Advisory Practice where he spent over 8 years’ providing Internal Audit Transformation services to hospitals and health systems across the east coast and was responsible for managing all phases of the internal audit function. He has extensive knowledge and experience with points of transition in hospital workflows, operations, administration, compliance, and governance. Mr. Ropiecki received a Bachelor’s degree in Cellular/Molecular Biology from Binghamton University and is a certified Project Management Professional.
Siddharth Saha, MHM, BSc. is the Vice President of Research for the Medical Technologies program area within Frost & Sullivan’s Healthcare & Life Sciences practice. In this role, Siddharth’s main function is providing thought leadership and big picture business implications of research conclusions to commercial and executive teams within stakeholder organizations in the healthcare space. Apart from providing operational and commercial leadership for the research business within the healthcare practice, he also uses his experience in hospital operational issues, clinical workflows and real time healthcare industry analysis to design, execute and deliver professional services based on actionable market insights and advisory services. Siddharth has a passion for analyzing the role of technology and innovative business models in solving the myriad of challenges the healthcare industry currently faces. He works closely with leading medical OEM’s, ICT firms, technology start-ups, new entrants in the value chain and, the investment community, as they assess commercially sustainable value propositions in the healthcare business sector.
Jonathan Machado is a Senior Investment Director at Samsung Next, Samsung's software & services innovation arm. At Next, Jonathan leads the investment effort in Health globally, including the investments in BigHealth, Healthy.io, and DayTwo. Jonathan works alongside Samsung Health executives to define Samsung’s strategy in the domain and identify trends that will disrupt the healthcare industry. Before joining Samsung NEXT, Jonathan was a Partner at Jerusalem Venture Partners (JVP) Labs, one of Israel's largest and most successful venture
Ms. Simin Yan joined Economic Mission of Israeli embassy in December 2017 as trade officer responsible for regulation and digital health sector.
She helps Israeli healthcare companies targeting in Chinese market with NMPA (former CFDA) registration and finding right partners.
November 2020, she took responsibility in elderly home project, one of the four China-Israel inno-friendship cooperation projects partnered with China Ministry of Science and Technology.
On behalf of Israeli Embassy, she built up relationship with Chinese leading elderly care service providers, aiming at facilitating more advanced Israeli technology coming into China.
Significant international business experience in driving international business development and strategy, including international market development, product/business portfolio management, delivering period result and pushing forward to reach strategic business target. Affluent experience in business liaison, building up international business relationship, managing cooperation among multiple parties.
Export and import expert with more than 10 years’ experience in Asian Pacific, North American, and European business development.
Adelphi University – Willemstad School of Business
Northwest A&F University
Haier Biomedical was founded to focus on design, manufacturing, marketing and sales of low temperature storage equipment for biomedical samples. Using the concept of IoT, the company has become a provider of comprehensive solutions for various biotechnological challenges. Operating globally, Haier Biomedical, the world’s only complete cold chain provider, has solutions storage for biological sample banks, blood safety, vaccine safety, medical supplies and reagent safety.
International Key Accounts Director
Development and management of Overseas Key Accounts to promote business development in overseas markets
European Market Director
Responsible for the company's European market business development, to ensure the completion of business targets. Through the establishment of a team, the development of channel network, achieve 80% growth in performance over the same period, reduce regional expenses by 50% and achieve high profit growth
98% The sales of H2 is doubled the sales in H1. The annual business revenue is 98% higher than that in 2018.
Practice business localization in UK, support and manage the growth of the reaching 50%
Since 1988 he is researcher of the ISS involved in the research and Health Service control activities.
His research activity is mainly in the field of Bioengineering of Cardiovascular System, evaluation of performance of Medical Device such as Heart Valve prosthesis, prosthetic vessels, stenting, mechanical support to circulation. More recently tissue engineering was a new interest to monitor cell activity under shear stress. Moreover the field of interest is widening thanks to the opportunity to head a specialised unit in biomechanics of the motion and rehabilitation activities. Biotelemetry and Telemedicine is the final complement of those activities.
Designing activity has been devoted to design and develop new tools for in vitro experiment as well as novel prototypes for bioengineering in the field of in vitro technology assessment such as implementation of test bench at the state of the art for complication potential due to the prosthetic flow field (Laser Doppler Anemometry, Particle Image Velocimetry) and to monitoring equipment for in vivo studies on animal (equipment set up for experimental trial) and in vivo non invasive measurement of physiological parameters. Scientific collaboration were set up with relevant research centres and university in the world (Achen, Sheffield etc).
The control activity was devoted to the technological assessment of medical device on the EU market following the harmonized European directives scheme together with the task of advisor for the competent authority within the national health service; HTA and wider eSurvey design were also tools developed for both medical device market (IT), assistive technologies needs and diffusion (WHO) and risk perception in radioprotection (EU).
Dissemination activities was set on different field such as hospital technical office regulation, authorization of operating theatres for organ transplant, technological assessment of medical devices particularly concerning cardiovascular pathology and telemedicine, eHealth and mHealth. Scientific work is comprised of more than 300 papers (H=21) and more communications, together with the head of national and international research projects.
Antonio Delli Gatti
For over 20 years Antonio has been working in Public Administration and Healthcare markets, covering the roles of Commercial Director at a territorial and national level. Since 2017, as Healthcare Director he works on the development and coordination of all commercial and production aspects of the entire E-Health proposition of the Group.
With approximately 12,000 professionals in 40+ locations (in Italy, Belgium, Germany, Norway, Serbia, Spain, Switzerland, Sweden, Argentina, Brazil, and the USA), the Engineering Group designs, develops, and manages innovative solutions for the areas of business where digitalisation generates major change, such as digital finance, smart government & e-health, augmented cities, digital industry, smart energy & utilities, and digital media & communication.
In the course of 2020, Engineering has supported its partners in the continuation and protection of their businesses and key processes, assisting in the design of their 'new normal' and the mapping of new digital ecosystems.
With its activities and projects, the Group is helping to modernise the world in which we live and work, combining specialist skills in the final frontier of technologies, technological infrastructures organised in a unique hybrid multi-cloud model, and the ability to interpret new business models.
With important investments in R&D, Engineering plays a leading role in research, coordinating national and international projects with a team of 450 researchers and data scientists and a network of scientific and academic partners throughout Europe. One of the Group's strategic assets is the expertise of its employees, whose development is promoted by a dedicated multi-disciplinary training school that provided more than 19,000 training days over the last year.
Giovanni Gorgoni is the CEO of AReSS Puglia, the regional government agency of Apulia Region for innovation in health and social care.
Currently he is also professor of Public Management at Bari LUM University, member of the executive board at EuroHealthNet (health promotion and health inequalities) and EHTEL (eHealth and telemedicine) and vice president of italian network NISAN (health clinical costing).
Previously he directed the apulian Health Department, two local health authorities and he has been facility manager, financial manager and operations manager in the healthcare sector between Rome and Milan.
Giovanni Gorgoni, born in 1971, is an economist with university degree in Business Economics at Milan Bocconi University, master degree in Healthcare Management at Milan Bocconi School of Management and master degree in Facility Management at Rome Campus Bio-Medico University.
He’s always been working in healthcare sector with different roles: advisor, private and public manager, professor.
His professional interests are public health, health communication, healthcare management, network and pathway designing, e-Health and care intelligence.
From December 2016 up till now is Chief Executive Officer of AReSS (Agenzia Regionale Strategica per la Salute e il Sociale Puglia), the Apulia government agency for strategic planning in health and social policies and for exploration in healthcare processes and technology. During current appointment he designed and developed seven regional clinical networks (cancer, rare disease, reumatology, hematology, stroke, heart and trauma), implemented eight value-based labs for Apulian Health System (clinical networks design, health pathways design, lean healthcare, health clinical costing, outcomes measurement, service humanization, communication for health and integrated care) and established the first regional center for telemedicine.
From October 2015 to November 2016 he was Head of Department for Health Promotion, Social Welfare and Sport for All - Apulia Region, accountable for administration of health and social policies for Apulia Region with organizational connection to regional government and annual budget of early € 7,2 billions. The main result of this appointment was the whole re-engineering of regional hospital network - 13.000 beds and 60 centers.
From January 2015 to October 2015 he was CEO of Lecce Local Health Authority in Apulia (7.900 employees, 6 hospitals, 148 community care sites and 803.000 citizens).
From July 2011 to December 2014 he was CEO of BAT Local Health Authority in Apulia (3.600 employees, 5 hospitals, 48 community care sites and 390.000 citizens).
Before July 2011 he served in Lazio Health System as CFO and COO at Viterbo Local Health Authority (2000-2008) and as Chief Facility Officer at Rome/E Local Health Authority (2008-2011).
Previously - in Milan - he worked as operations manager in Humanitas Clinical Institute and as healthcare consultant in KPMG Advisory.
Currently he’s member of Executive Board of National Program for Chronic Diseases and professor in Public Management at Bari LUM University.
From February 2018 he’s included in national register of eligible Healthcare CEOs.
Anat Katz serves in Israel's Consulate General in NY as Minister, Economic and Trade Affairs, U.S. and Canada. In this capacity Anat is responsible for promoting Israeli business engagements, exports, research and development collaborations with Canada and U.S. based companies and attracting investments to Israel.
Prior to this Anat held a number of positions in the Israeli Ministry of Economy including Senior Director, Head of the Israeli Ministry of Economy and Industry's Export Control Agency, Head of the America's desk in the Foreign Trade Administration. Anat also served as the head of Israel's Trade mission in Washington D.C. and in Singapore.
In-between Anat also headed the International Affairs Division of the Israeli parliament, the Knesset, where she promoted inter-parliamentary ties between the Knesset and the Israeli parliamentarians and their foreign counterparts.
Anat holds an MBA and a B.Sc. in laws (Honors Program) from the Hebrew University in Jerusalem. She is a graduate of a directors' course administered by the Bar Ilan University, as well as of the Ministry of Economy and Industry's prestigious Cadet Course.
Anat is a certified lawyer in Israel. She is married to Tal and is a mother of two boys.
Dr. Aviv Gladman
Dr. Gladman is a licensed electrical and medical engineer who was mystified by the disconnect between clinicians and technology and went on to train in medicine. He sits on the board of directors of the Mackenzie Innovation Institute and is a member of the Health Canada Scientific Advisory Committee on Digital Health Technologies. As Chief Information Officer and Chief Medical Information Officer at Mackenzie Health, he has a leadership role in applied innovation and healthcare technology, and more than a decade of clinical practice in adult critical care medicine. He is a graduate of the University of Toronto Engineering Science program (1994), Institute of Biomedical Engineering (1997), and School of Medicine (2003). His areas of expertise include ambiently intelligent healthcare workflow automation, the Internet of Healthcare Things, electronic health record system interoperability, and clinical change management.
Dr. Rafi Hofstein
Dr. Hofstein came to Toronto from Israel in 2009 to assume the position of President & CEO of a newly formed organization called MaRS Innovation (recently renamed as Toronto Innovation Acceleration Partners, TIAP). At this position, Dr. Hofstein led the creation of over fifty start-up companies primarily in the healthcare space. Among the companies of primary note are Triphase, Fibrocor and Notch Therapeutics in which Dr. Hofstein has been a cofounder and a director. In addition, Dr. Hofstein is a member of the board of several not-for-profit organizations in Quebec and Ontario.
Prior to coming to Canada, Dr. Hofstein served as the President & CEO of Hadasit (the tech transfer company of Hadassah, Jerusalem) and the chairman of Hadasit Bio Holding (a holding company listed on the Tel-Aviv Stock Exchange). One of the companies Dr. Hofstein co-founded and joined as a director is BiolineRx, an Israeli biotech company listed on NASDAQ.
Dr. Hofstein received his Ph.D. from the Weizmann Institute of Science (Rehovot, Israel) and his postdoctoral training at Harvard Medical School. Dr. Hofstein also had a long tenure in the IDF and retired as a colonel after serving in the reserve troops for over twenty years.
Dr. Bradley Strauss
Dr. Bradley Strauss obtained his MD cum laude from the University of Toronto in 1982. He completed his Residency Training in Internal Medicine at the University of Toronto in 1986 and then a Clinical Fellowship in Cardiology at the University of Ottawa Heart Institute in 1988. Subsequently he was awarded a Research Fellowship from the Heart and Stroke Foundation to do research work at the world-famous Thoraxcenter in Rotterdam, the Netherlands under the supervision of Professor Patrick Serruys. During his time in Rotterdam, he obtained a PhD from Erasmus University for his work on coronary stenting and the arterial response to stenting injury.
He recently completed a 10-year term as Chief of the Schulich Heart Program and Head of the Division of Cardiology at Sunnybrook Health Sciences Centre in Toronto, Canada. He holds the Reichmann Chair in Cardiovascular Research, and is a Professor of Medicine and Professor of Laboratory Medicine and Pathobiology at the University of Toronto.
His main clinical activity is interventional cardiology. He has been active in both basic research (arterial response to injury, angiogenesis) and clinical research related to interventional research and coronary imaging. He has authored more than 200 papers and has served on the Editorial Board of 5 journals. He holds 12 patents. He has founded a company, Matrizyme Pharma, to commercialize the use of collagenase to soften the plaque in order to facilitate guidewire crossing in chronic total occlusions. Matrizyme Pharma has completed Phase 1 and Phase 2 Clinical trials. He is one of the co-Founders of the Medvention Innovation Program at Sunnybrook Health Sciences Center.
Ms. Ayelet Karp, leads Israel’s Trade and Economic mission in Ghana and West Africa. Prior to her appointment in Ghana, Ayelet worked at the Ministry of Economy and Industry in the Strategic Planning Department, leading various projects aimed at enhancing innovation and growth of the Israeli manufacturing sector.
Ayelet is an Alumni of Israel’s prestige civil service cadets program, and holds a Master's degree in public policy as well as an BA in Psychology and Biology and MA in Synthetic Biology.
Andrea Belardinelli is Director of the Digital Health and Innovation Sector of the Health and healthcare rights Department of the Tuscany Region.
He was Staff Coordinator of the Business Management Unit of AOU Careggi (Careggi Teaching Hospital in Florence) and Director of the Innovation, Control and Quality Area and of the Integration and Communication Area (2013-2018).
Director of Planning and Innovation Area of the Livorno Local health authority (USL 6 Livorno 2010-2013). CIO of the Arezzo Local health authority (USL8 Arezzo 2006-2009).
He has a degree in Electronic Engineering with specialization in Computer Science and Bioengineering.
From 1994 to 2006 he was a researcher at the Institute of Clinical Physiology of the National Research Council of Pisa (CNR), carrying out applied research activities, with the design and development of biomedical devices dedicated to the patient and applications of Telemedicine, also in extreme environments, both at national and international levels (Formula One World Championship - Ferrari and Toyota teams, Directorate General for Research of the European Commission, etc.). He has collaborated with many leading private companies in the field of microelectronics, automation and ICT.
He has also carried out intense teaching activities in large private companies, public bodies and italian Regions and has been invited speaker at numerous conferences and workshops.
He is patent author for industrial inventions, and software applications registered with the SIAE mark and of numerous scientific publications in biomedical field. He has received several national and international innovation awards.